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Abstract 
Introduction: Current lifestyle interventions for the treatment of type 2 diabetes and weight loss 
show limited effects, while the promotion of psychological well-being has shown preliminary 
benefits in reducing psychological distress and improving self-care behaviors in type 2 diabetes and 
weight loss. 
Objectives: The aim of this study was to evaluate the feasibility, acceptability, and superiority of a 
4-month combined well-being and lifestyle intervention for weight loss and distress reduction 
among adult patients with type 2 diabetes and overweight/obesity compared to lifestyle intervention 
alone. Primary efficacy outcomes included changes in weight, psychological distress, and well-
being, while secondary efficacy outcomes included changes in lifestyle and physiological 
parameters.  
Methods: In this multicenter RCT, 58 consecutive patients were recruited from two outpatient 
endocrinology clinics and randomized to either a combined WBT-lifestyle group, receiving the 
combined well-being and lifestyle intervention (n=30), or a lifestyle alone group, receiving a 
lifestyle intervention only (n=28). Data were collected at baseline (T0), at immediate post-
intervention (T1), and at a 6-month follow-up (T2).  
Results: The study intervention was shown to be feasible and acceptable. Compared to the lifestyle 
alone group, the combined WBT-lifestyle group showed significantly greater improvements in 
levels of depression, hostility, and personal growth at T1 and in levels of physical activity at T2. 
There were no significant differences between treatment groups in measures of weight and other 
physiological parameters at any assessment points. However, significant improvements were 
observed from T0 to T2 in weight in both treatment groups, and in blood pressure in the combined 
WBT-lifestyle group.  
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Conclusions: The findings suggest that a well-being intervention can be a valuable addition to 
lifestyle interventions in improving short-term psychological outcomes and promoting healthy 
changes in physical activity at a 6-month follow-up.  
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Chapter 1: THE ROLE OF OBESITY IN TYPE 2 DIABETES 
 
1.1 Type 2 diabetes 
1.1.1 Definition and diagnosis 
Diabetes mellitus, hereafter simply diabetes, is a chronic, non-communicable metabolic disorder 
characterized by impaired glucose metabolism and consequent chronic hyperglycemia (American 
Diabetes Association, 2020c; World Health Organization, 2020a). Broadly speaking, diabetes is 
caused by either an absolute or relative deficiency of insulin, a hormone produced by the beta cells 
of the pancreas that is responsible for lowering levels of glucose in the blood through uptake into 
organs and muscles. Peripheral resistance to the action of insulin (i.e., the body is not able to 
effectively use the insulin produced in the pancreas) results in relative deficiency, while impairment 
in insulin secretion (i.e., the pancreas does not produce enough insulin) results in an absolute 
deficiency (American Diabetes Association, 2020c; World Health Organization, 2020a).  
The term diabetes encompasses a group of disorders characterized by different clinical 
presentation and pathophysiology. Type 2 diabetes is the most common form, accounting for more 
than 90% of all cases (Xu et al., 2018). In type 2 diabetes, a form of non-insulin dependent diabetes, 
the pancreas is still producing insulin and hyperglycemia is due to a diminished response of the 
body’s organs and muscles to insulin, also called insulin resistance (American Diabetes 
Association, 2020c; World Health Organization, 2020a). Other forms of diabetes are less common 
and include type 1 diabetes, gestational diabetes, monogenic diabetes (i.e., maturity-onset diabetes 
of the young or MODY), and secondary diabetes (American Diabetes Association, 2020c; World 
Health Organization, 2020a). Type 1 diabetes comprises 5% to 10% of all cases of diabetes and is 
an autoimmune condition that results in the destruction of pancreatic beta cells, leading to 
dependence on external sources of insulin, or insulin dependent diabetes (American Diabetes 
Association, 2020c; World Health Organization, 2020a). Gestational diabetes is a type of non-
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insulin dependent diabetes that is first diagnosed in pregnancy in a patient without a pre-existing 
diagnosis of diabetes. This condition affects 7% of all pregnancies, increasing the risk of 
complications during pregnancy for both the mother and the fetus and the risk of developing type 2 
diabetes in the future for both the mother and child (American Diabetes Association, 2020c; World 
Health Organization, 2020a). Finally, monogenic diabetes affects about 1% to 5% of all cases of 
diabetes and is caused by a genetic mutation, while secondary diabetes may be the consequence of 
other systemic diseases (e.g., hemochromatosis), drugs (e.g., corticosteroids), or complications of 
another disease affecting the pancreas (e.g., chronic pancreatitis) (American Diabetes Association, 
2020c). 
A diagnosis of diabetes is usually made with either a blood hemoglobin A1c (hbA1c) ≥ 6.5% or 
a fasting plasma glucose (FPG) ≥ 126 mg/dL. HbA1c is a measurement of the percentage of 
glycated hemoglobin in the blood and provides a general measure of the level of blood glucose 
control over the preceding 3 months, while FPG is the level of glucose in the blood after 8 hours of 
overnight fasting. Another standard test is the 2-hour Oral Glucose Tolerance Test (OGTT), which 
assesses blood glucose levels before and 2 hours after the ingestion of 75 mg of glucose. A plasma 
glucose (PG) level in the 2-hour sample > 200 mg/dL is diagnostic of diabetes (American Diabetes 
Association, 2020c). An intermediate condition of pre-diabetes is commonly described following an 
impaired glucose tolerance (IGT) reading (i.e., a 2-hour PG during 75-g OGTT from 140 mg/dL to 
199 mg/dL), impaired fasting glycemia (IFG) reading (i.e., FPG levels between 100 mg/dL and 125 
mg/dL), and/or a hbA1c between 5.7% and 6.4% (American Diabetes Association, 2020c). Pre-
diabetes represents a significant risk factor for the development of diabetes and cardiovascular 
disease (Richter, Hemmingsen, Metzendorf, & Takwoingi, 2018; Zhang et al., 2010).  
 
1.1.2 Prevalence and epidemiology 
The global prevalence of diabetes among adults has almost doubled during the past three 
decades, rising from 4.7% in 1980 to 8.5% in 2014 (World Health Organization, 2020a; Zimmet et 
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al., 2014). A similar trend has been observed in the Italian population from 1980 to 2013, where the 
prevalence of diabetes has increased from 3.3% to 7.1% in men and from 4.7% to 6.8% in women 
(Gnavi et al., 2018). Higher estimates have been observed in the USA, where the prevalence of 
diabetes among adults rose from 9.5% in 1999-2002 to 12% in 2013-2016, reaching a prevalence of 
13% in 2018 (Centers for Disease Control and Prevention, 2020c), and the prevalence is expected to 
keep increasing in the next couple of decades (Khan et al., 2020). According to the International 
Diabetes Federation Diabetes Atlas, the global prevalence of diabetes was estimated to be 9.3% in 
2019, and an increase to 10.2% and 10.9% is expected by 2030 and 2045, respectively (Saeedi et 
al., 2019). Even if these figures often do not distinguish between type 1 and type 2 diabetes, it has 
been reported that the increase in diabetes in the past decades is mostly related to the rise of type 2 
diabetes (World Health Organization, 2020a). Furthermore, data on the prevalence and incidence of 
type 2 diabetes are likely to be underestimated because around 1 in 3 people with diabetes are 
thought to be undiagnosed (Saeedi et al., 2019). Due to their large populations, the USA, China, and 
India are the countries with the highest total number of cases of type 2 diabetes in the world (Khan 
et al., 2020). While the prevalence of type 2 diabetes has been increasing in all countries 
independently of their incomes, new cases are increasing faster in low and middle-income countries 
compared with high-income countries (Khan et al., 2020; World Health Organization, 2020b).  
The prevalence of diabetes generally increases with age. In the USA, new cases of diabetes 
are higher among people who are 45 years or older, with a prevalence of 26.8% among people 65 
years of age or older, 17.5% among people between 45 and 64 years of age, and 4.2% among 
people between 18 and 44 years of age (Centers for Disease Control and Prevention, 2020c). This 
age-related trend is characteristic of type 2 diabetes, while type 1 diabetes is more commonly 
diagnosed during childhood and adolescence. However, the prevalence of type 2 diabetes is 
currently increasing among children, adolescents, and young adults as well (Centers for Disease 
Control and Prevention, 2019a).  
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The prevalence of diabetes differs among people based on socio-economic status, though 
different patterns are seen in countries based on their level of economic development. In high-
income countries, diabetes disproportionally affects people with a low socio-economic status 
(Agardh et al., 2011), while in low and middle-income countries a higher prevalence of diabetes has 
been observed in people with higher income and higher levels of education (Seiglie et al., 2020). 
The prevalence of diabetes is higher among ethnic and racial minorities. In the USA, 22.1% of 
Hispanic people, 20.4% of non-Hispanic black people, and 19.1% of Asian people had a diagnosis 
of diabetes between 2011 and 2016 compared to 12.1% of non-Hispanic white people (Cheng et al., 
2019). Finally, sex differences in the prevalence of type 2 diabetes do not appear to be significant, 
with a slightly higher prevalence among men < 60 years and among women > 65 years (Centers for 
Disease Control and Prevention, 2020c; Khan et al., 2020). 
 
1.1.3 Risk factors 
Various genetic and environmental factors have been implicated in the development of type 
2 diabetes (Franks et al., 2013; Zheng et al., 2018). 
Type 2 diabetes has a stronger genetic component than type 1 diabetes (Zheng et al., 2018). 
It has been estimated that people with one first-degree relative with type 2 diabetes are 2.5 times 
more likely to develop the disease. The risk of developing the disease is even higher when two or 
three family members have type 2 diabetes (Scott et al., 2013). A meta-analysis of data from twin 
studies showed a 72% heritability for type 2 diabetes, with a higher concordance rate among 
monozygotic twins than dizygotic twins (Willemsen et al., 2015). Genome-wide association studies 
have identified several loci that affect insulin secretion and action, suggesting that type 2 diabetes is 
a highly polygenic disease (Fuchsberger et al., 2016). However, the rapid rise of the diabetes 
epidemic in association with major lifestyle changes in modern society along with data showing 
that lifestyle modification can prevent the development of the disease suggest a significant 
contribution from environmental factors to the disease (Sumamo Schellenberg et al., 2013).    
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The main environmental risk factors for type 2 diabetes, also referred to as modifiable risk 
factors, include obesity, lack of physical activity, and unhealthy diet (Chatterjee et al., 2017). Being 
overweight or obese represents the strongest risk factor for the development of type 2 diabetes 
(Bellou et al., 2018). In fact, the prevalence of type 2 diabetes increases linearly with BMI (Nguyen 
et al., 2011), most patients with type 2 diabetes are also overweight or obese (World Health 
Organization, 2020c), and abdominal obesity, weight gain since young adulthood, and visceral 
adiposity are all independent risk factors of type 2 diabetes (Bozorgmanesh et al., 2011; Jafari-
Koshki et al., 2016; Zheng et al., 2018). One of the possible mechanisms by which these factors can 
induce type 2 diabetes is via adipose (i.e., fat) tissue. Excessive adipose tissue promotes various 
inflammatory mechanisms, including free fatty acid release and adipokine dysregulation, that lead 
to insulin resistance (Galicia-Garcia et al., 2020). 
Another major modifiable risk factor for type 2 diabetes is lack of physical activity. A linear 
association between sedentary behaviors and type 2 diabetes has been found in numerous studies, 
with total sedentary time and time spent watching TV being associated with an increased risk for 
type 2 diabetes (Grøntved & Hu, 2011; Patterson et al., 2018). On the other hand, an increase in 
physical activity has been shown to both prevent the development of type 2 diabetes and improve 
glucose control and reduce disease complications in patients with a diagnosis of type 2 diabetes 
(Warburton et al., 2006). For example, in a meta-analysis of longitudinal studies in the general 
population, 150 minutes of moderate per week has been associated with a risk reduction of 26% for 
the development of type 2 diabetes, with even higher levels of physical activity being associated 
with a risk reduction of up to 56% (Smith, Crippa, Woodcock, & Brage, 2016). In patients with 
type 2 diabetes, regular physical activity can improve metabolic parameters and vascular health, 
reduce inflammation, and promote weight loss (Kirwan et al., 2017). 
Diet is another important factor in the prevention and management of type 2 diabetes. 
Although controlling overall energy intake is important, the quality of the diet rather than quantity 
is what appears to be more important for the prevention and management of type 2 diabetes 
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(Bhupathiraju et al., 2014). More specifically, most guidelines recommend avoiding or reducing the 
consumption of red or processed meats, refined grains and sugar, and foods high in sodium and 
trans-fat due to their negative impact on weight and cardiovascular health, while consuming 
vegetables, fruits, whole grains, legumes, nuts, and dairy products in moderation (Forouhi et al., 
2018). A healthy diet, along with physical activity, has been associated with a reduced risk of type 2 
diabetes (Hemmingsen et al., 2017). Moreover, a diet rich in vegetables, such as the Mediterranean 
diet, may reduce the risk of developing type 2 diabetes by 19% and 23% and has been associated 
with better glycemic control and reduction of cardiovascular risk factors compared to control diets 
among patients with type 2 diabetes (Esposito et al., 2015).  
Finally, another two factors that can have an impact on type 2 diabetes are alcohol consumption and 
tobacco use. The risk of type 2 diabetes increases linearly with the number of cigarettes smoked 
(Maddatu et al., 2017). However, a moderate consumption of alcohol (i.e., < 63 g/day) has been 
associated with a reduced risk of type 2 diabetes compared to complete abstinence or higher 
consumption (Knott et al., 2015), and with improvements in insulin sensitivity and lipid profile 
(Joosten et al., 2008). 
 
1.1.4 Consequences and complications 
Common symptoms of diabetes are related to hyperglycemia and include increased urination, 
thirst, hunger, and fatigue, blurred vision, and poor wound healing (American Diabetes Association, 
2020c; World Health Organization, 2020a). Weight loss is a common presenting symptom in type 1 
diabetes due to the body’s inability to derive energy from glucose due to absence of insulin, type 2 
diabetes is associated with overweigh and obesity due to these conditions’ presumptive effects on 
peripheral insulin resistance (American Diabetes Association, 2020c). Although presenting 
symptoms of type 1 and 2 diabetes may be similar, symptoms generally occur suddenly in type 1 
diabetes, often in an acute presentation following a triggering event such as an illness. Type 2 
diabetes progresses slowly and symptoms are often mild or absent in the earliest stages of the 
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disease as the body slowly loses the ability to control blood glucose levels (American Diabetes 
Association, 2020c).  
Diabetes is associated with both acute and chronic complications. The two most common 
acute complications of diabetes are diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar 
state (HHS) (Kitabchi et al., 2009).  DKA is a syndrome of hyperglycemia, dehydration, and 
reliance of the body on ketones for energy due to an inability to utilize glucose which results in 
metabolic acidosis (Eledrisi & Elzouki, 2020). While this complication is more common in type 1 
diabetes following an acute event such as trauma, surgery, or a systemic infection, it can also occur 
in patients with type 2 diabetes (Eledrisi & Elzouki, 2020; Kitabchi et al., 2009; Newton & Raskin, 
2004). HHS is characterized by severe hyperglycemia, dehydration, and hyperosmolality, or 
concentrated blood, in the absence of significant acidosis (Stoner, 2017). This complication is more 
common in patients with type 2 diabetes, mostly among the elderly or during the initial presentation 
of the disease among young adults and teenagers (Kitabchi et al., 2009). Both DKA and HHS are 
life-threatening complications and require emergency medical care. Untreated, DKA can lead to 
coma, cardiac arrest, thromboembolism, and cerebral edema (Misra & Oliver, 2015), while HHS 
can be associated with seizures, coma, and acute renal failure (Stoner, 2017). 
Over time, chronic hyperglycemia can lead to chronic complications due to damage to blood 
vessels and nerves, resulting in microvascular complications such as nephropathy, neuropathy, and 
retinopathy, and macrovascular complications such as coronary artery disease, peripheral artery 
disease, and cerebrovascular disease (Zheng et al., 2018). These complications are common, and it 
has been estimated that microvascular complications affect half of all patients with type 2 diabetes, 
while macrovascular complications affect about one-third of all patients (Litwak et al., 2013). 
Accordingly, treatment of type 2 diabetes has been associated with a risk reduction > 10% of 
developing microvascular and macrovascular complications (Henning, 2018). In particular, 
cardiovascular disease and nephropathy are the major causes of mortality and disability among 
patients with type 2 diabetes (Braunwald, 2019; Glovaci et al., 2019). Globally, CVDs affect 32.2% 
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of all patients with type 2 diabetes (Einarson et al., 2018), while diabetic nephropathy affects about 
one-third of all patients with diabetes (Reutens & Atkins, 2011). Over time, diabetic nephropathy 
can lead to renal failure and the need for dialysis or renal transplant (Reutens & Atkins, 2011). 
Diabetic retinopathy can lead to moderate or severe vision loss and permanent visual impairment, 
and in the USA, vision disability, including blindness, affected 11.7% of adult patients with 
diabetes in 2018 (Centers for Disease Control and Prevention, 2020c). Finally, peripheral 
neuropathy affects almost half of all patients with diabetes and it is associated with an increased 
risk of foot ulcers, infections, and in severe cases lower-limb amputation (Hicks & Selvin, 2019). 
As a result of these complications, diabetes is associated with high rates of disability and 
reduced life expectancy worldwide. In 2017, type 2 diabetes was the 9th leading cause of mortality 
(Khan et al., 2020). CVD is the major cause of mortality in patients with diabetes, accounting for 
half of all deaths (Einarson et al., 2018). The impact of diabetes is not limited to its direct effect on 
health but also the increased economic burden it entails. For example, in the US the cost burden of 
diabetes in 2017 reached $327.2 and $31.7 billion for people with diagnosed and undiagnosed 
diabetes, respectively (Dall et al., 2019), and people with diabetes have medical expenditures about 
2.3 times higher than those without diabetes. There are additional indirect costs related to increased 
absenteeism, reduced productivity, and inability to work because of disease-related disability 
(American Diabetes Association, 2018). 
 
1.2 Overweight and obesity  
1.2.1 Definition and classification  
 Overweight and obesity are conditions characterized by excessive fat accumulation. The 
most commonly used standardized measure to estimate body fat and categorize individuals as 
overweight or obese is the Body Mass Index (BMI), which is calculated by dividing a person’s 
weight in kilograms by the square of their height in meters (kg/m2). Among adults, overweight is 
defined by a BMI between 25 and 29.9 kg/m2, while obesity is defined by a BMI ≥ 30 kg/m2. 
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Obesity is also further categorized as obesity class I (BMI between 30 and 34.9 kg/m2), class II 
(BMI between 34.9 and 39.9 kg/m2), and class III (BMI ≥ 40 kg/m2) (World Health Organization, 
2020b). While this classification applies to the Western world, the threshold for overweight and 
obesity is lower in Asian and South Asian populations, where a BMI between 23 and 24.9 kg/m2 
indicates overweight and a BMI ≥ 25 kg/m2 indicates obesity (Nishida et al., 2004). Despite being 
criticized for not taking into consideration individual variations in body composition, adiposity 
distribution, and lean body mass (Buss, 2014), BMI is considered clinically significant because a 
BMI ≥ 25 kg/m2 has been associated with an increased risk of comorbidities such as diabetes, 
hypertension, and coronary artery disease, and with overall increased morbidity and mortality 
(Abdelaal et al., 2017). 
 Another common measure of body fat that has been associated with important clinical 
outcomes is abdominal circumference. In particular, a waist circumference ≥ 102 cm in men and ≥ 
88 cm in women has been associated with greater health risks as well (Abdelaal et al., 2017). 
 Other more accurate measures of adiposity include the body adiposity index, waist-to-hip 
ration, air displacement plethysmography, bioelectrical impedance weighing scale, magnetic 
resonance imaging (MRI), intra-organ fat quantification (MRS), and dual-energy X-ray 
absorptiometry (DEXA), but are all less commonly used due to increased cost and reduced access 
(Borga et al., 2018).    
 
1.2.2 Prevalence and epidemiology 
Overweight and obesity are important clinical and public health challenges, representing a 
current global epidemic and public health crisis (World Health Organization, 2020b). The global 
prevalence of obesity has significantly increased from 1975 to 2014 from 3.2% to 10.8% among 
men and 6.4% to 14.9% among women (Di Cesare et al., 2016). This trend is expected to increase, 
and by 2025 the global prevalence of obesity is expected to reach 18% in men and higher than 21% 
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in women (Di Cesare et al., 2016). The combined prevalence of overweight and obesity is expected 
to reach 57.8% by 2030 (Kelly et al., 2008). 
Epidemiology data show the prevalence of obesity varies based on age, gender, education, 
race/ethnicity, and income (Centers for Disease Control and Prevention, 2020c). In the US, for 
example, the prevalence of obesity in 2017 and 2018 was the highest among middle-aged adults 
between 40 and 59 years of age, non-Hispanic black people, and people with lower levels of 
education. A different trend in education and obesity was observed among non-Hispanic black men 
for whom the prevalence of obesity increased linearly with education. While there were no 
differences between men and women in the prevalence of obesity, women had a higher prevalence 
of severe obesity, defined as a BMI ≥ 40 kg/m2. Moreover, the prevalence of obesity was the 
highest in the middle-income group among men, with the exception of non-Hispanic black men for 
whom obesity prevalence was the highest in the high-income group. Among women, the prevalence 
of obesity was the highest in both the middle and low-income groups, with the exception of non-
Hispanic black women, for whom the prevalence of obesity did not differ by income group (Centers 
for Disease Control and Prevention, 2020c). Finally, in underdeveloped and low to middle income 
countries, a higher socioeconomic status has been associated with a higher BMI, while the opposite 
trend was observed in developed countries, where a lower socioeconomic status has been associated 
with a higher BMI (S. Newton et al., 2017). 
 
1.2.3 Risk factors 
 Overweight and obesity are the result of an imbalance between caloric intake and energy 
expenditure, and a variety of biological, genetic, environmental, behavioral, and psychosocial 
factors are involved in the development of overweight and obesity (World Health Organization, 
2020b). 
 Biological factors related to overweight and obesity generally involve abnormalities that 
affect the hormones responsible for the regulation of the hunger-satiety mechanism such as ghrelin 
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and leptin (Jehan et al., 2020). Ghrelin is a hormone that stimulates the hunger center of the brain 
located in the hypothalamus, while leptin suppresses appetite by signaling the brain satiety centers 
(Austin & Marks, 2009). A dysfunction in the action of these hormones, seen in conditions like 
congenital leptin deficiency and acquired lesions of the hypothalamus, can lead to hyperphagia and 
weight gain (Timper & Brüning, 2017).  
Genetic factors can also be involved in the etiology of obesity (Thaker, 2017). Adoption and 
twin studies have found significant correlations in weight between adopted individuals and their 
biological parents as well as twin pairs, showing a heritability between 45% and 90% (Bouchard et 
al., 1990; Silventoinen et al., 2010; Stunkard et al., 1986). Broadly speaking, the three main genetic 
causes of obesity are: monogenic, in which a single gene mutation is involved; syndromic, in which 
obesity is associated with a mutation in one or multiple genes along with other neurodevelopmental 
or systemic developmental conditions; and polygenic, in which the effect of a variety of genes 
interact with each other and environmental risk factors for obesity (Jehan et al., 2020; Thaker, 
2017).  
Other behavioral factors such as poor sleep (Ogilvie & Patel, 2017), smoking cessation 
(Chao et al., 2019), excessive alcohol consumption (Traversy & Chaput, 2015), and the side effect 
of some medications such as antipsychotics, antidepressants, lithium, anticonvulsants, insulin, and 
glucocorticoids may also contribute to the development of overweight and obesity (Carver, 2006; 
Shrivastava & Johnston, 2010). 
 With respect to psychosocial factors, various forms of psychological distress such as 
depression, anxiety, and binge eating disorder have been associated with an increased risk of 
obesity (Sarwer & Polonsky, 2016).  
 
1.2.4 Consequences and complications 
 Obesity is associated with a greater risk for all-cause mortality (Abdelaal et al., 2017). There 
is evidence that even among those with a BMI in the normal range, being overweight or obese in 
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the past may lead to a higher mortality rate compared to those who have always had a normal 
weight, highlighting the importance of prevention (Xu, Cupples, Stokes, & Liu, 2018). 
 This increase in mortality may be linked to the various associated comorbidities. Both 
overweight and obesity have been associated with a higher incidence of type 2 diabetes, various 
cancers (i.e., breast, endometrial, ovarian, colorectal, and kidney cancer), CVD (i.e., hypertension, 
stroke, and coronary artery disease), asthma, gallbladder disease, osteoarthritis, and chronic back 
pain (Guh et al., 2009). The relationship between weight, CVD, and type 2 diabetes is particularly 
important (WHO, 2016), and overweight and obesity account for 35% of all cases of ischemic heart 
disease and 55% of all cases of hypertension (Frühbeck et al., 2013). Moreover, the prevalence of 
type 2 diabetes increases linearly with BMI (Nguyen et al., 2011), and about 65-80% of diabetic 
patients are overweight or obese (World Health Organization, 2020c). Other comorbidities include 
kidney disease, non-alcoholic fatty liver disease, infertility, gastroesophageal reflux disease, and 
sleep apnea (Abdelaal et al., 2017). Severe obesity can also impact physical functioning, such as the 
ability to walk or climb stairs, therefore interfering with daily activities, and it has generally been 
associated with a poor health-related quality of life (Abdelaal et al., 2017; Felix et al., 2020). 
 Finally, obesity has a great economic impact on both the individual and society overall. The 
economic burden of obesity results from a combination of increased health care expenditure, lost 
productivity, increased mortality, and disability (Tremmel et al., 2017). In the US, for example, the 
global economic impact of obesity was estimated to account for 2.8% of the 2014 global gross 
domestic product (Tremmel et al., 2017). 
 
1.3 Management of type 2 diabetes and overweight/obesity  
 Due to the high prevalence of overweight and obesity among patients with type 2 diabetes, it 
is difficult to discuss the management of type 2 diabetes without discussing weight management. In 
fact, weight loss is considered the single most important goal in the management of diabetes 
(American Diabetes Association, 2020e; Franz et al., 2015). Therefore, interventions in patients 
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with type 2 diabetes who are also overweight or obese focus on both glycemic control and a 
reduction in weight that is sustained over time. Although the diagnosis of diabetes is made at a 
hbA1c of 6.5%, the target for individuals with diabetes is usually 7%, because attempts at stricter 
control often have deleterious side effect (American Diabetes Association, 2020d). Reaching a state 
of glycemic control is associated with a reduction in diabetes-related complications (American 
Diabetes Association, 2020d). About weight, it has been suggested that a modest weight loss of at 
least 5% of the initial weight can improve health outcomes, including glucose levels, blood 
pressure, and lipid profile, and to reduce the need of medication for glucose-lowering medications 
(Brown, Buscemi, Milsom, Malcolm, & O’Neil, 2016; Wing et al., 2011). Other important targets 
of treatment are the management of eventual macrovascular and microvascular complications to 
reduce mortality, eventual impairments in the control of other physiological parameters like lipid 
profile and blood pressure, albuminuria levels, inflammation markers, bone mineral density, and 
reduction in other deleterious lifestyles like smoking and alcohol consumption (American Diabetes 
Association, 2020b). In individuals that do not have a diagnosis of type 2 diabetes but are at risk for 
this, like in pre-diabetes, the goal of the intervention is to prevent the progression of the disease, its 
complications, and mortality (American Diabetes Association, 2020f). Modest and sustained weight 
loss can delay the progression to type 2 diabetes in patients with pre-diabetes (American Diabetes 
Association, 2020e). 
Various options are commonly employed for the management of type 2 diabetes and 
overweight/obesity, including lifestyle interventions, medications, and surgery. These managements 
tools often overlap in purpose, since the management of diabetes and overweight/obesity will have 
a benefit on the management of the other. 
 
1.3.1 Lifestyle interventions 
Lifestyle interventions are considered a first-line treatment for both type 2 diabetes and 
obesity. These are usually comprehensive multicomponent interventions, including a combination 
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of diet, physical activity, and behavioral therapy, delivered by a multidisciplinary team of 
dieticians, psychologists, physicians, and clinicians trained in exercise physiology, and can be 
delivered in various settings: in person or online, in group or individual sessions. Taken together 
these components are important both for weight and glycemic control (American Diabetes 
Association, 2017b; Kushner, 2014). 
The diet component, or nutrition therapy, in patients with type 2 diabetes usually promotes 
the consumption of nutrient-dense, high-quality foods. In general, it is recommended to consume 
foods that are high in fiber and low in glycemic load (a standardized measure of how much a given 
food will raise an individual’s blood glucose following consumption), like whole grains, vegetables, 
fruits, legumes, and some dairy products, to consume foods rich in omega-3 fatty acids, to avoid 
sugar-sweetened beverages, to minimize foods with added sugar, to limit sodium intake, and to 
consume a moderate amount of alcohol (American Diabetes Association, 2017b). Examples of 
healthy dietary plans are the Mediterranean diet, the Dietary Approaches to Stop Hypertension 
(DASH) diet, and plant-based diets (Papamichou et al., 2019). However, there is no one specific 
plan that fits all patients, and therefore it is recommended that all patients receive individualized 
medical nutrition therapy by a registered dietician (Evert et al., 2013). For those patients that also 
need to lose weight, the diet is designed to promote an overall reduction in energy/calorie intake. 
Common hypocaloric diet regimens for weight loss may include very low-energy diets that restrict 
calorie intake to 800 kilocalories (kcal) a day and often include meal replacement products (e.g., 
energy bars, shakes), and low-energy diets that restrict calorie intake to 800-1,500 kcal a day and 
likewise may include both regular food and meal replacement products (American Diabetes 
Association, 2017b; Kushner, 2014).  
Physical activity and exercise are recommended in patients with diabetes. General 
recommendations for adults include engaging in at least 150 minutes of moderate or vigorous 
physical activity a week, distributed between at least 3 days with no more than 2 consecutive days 
without physical activity, combined with 2-3 sessions of resistance exercises on nonconsecutive 
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days, and reducing time spent in sedentary behaviors (American Diabetes Association, 2017b). For 
weight loss, the main goal of physical activity is to increase energy expenditure while reducing 
energy intake (Kushner, 2014).  
Behavioral components are usually combined with diet and physical activity and commonly 
include stimulus control, goal setting, problem solving, self-monitoring, and cognitive restructuring 
to identify and modify negative thoughts and emotions that may interfere with weight management 
(American Diabetes Association, 2017b; Wadden & Bray, 2019). It is recommended that all 
patients with diabetes participate in Diabetes Self-Management Education and Support, a 
comprehensive approach to diabetes education and management that aims to instill the necessary 
knowledge and skills for diabetes self-management (American Diabetes Association, 2017b). 
In patients with a diagnosis of type 2 diabetes, comprehensive lifestyle interventions that 
combine these three components in a structured way can have beneficial effects on glycemic 
control, lipid profile, glucose tolerance, and insulin resistance (Wing et al., 2010). Lifestyle 
interventions that include a combination of energy restriction, regular physical activity, and 
frequent contacts may achieve a weight loss of at least 5% (Franz et al., 2015; Wing, 2001). One 
particularly significant example was a large multicenter RCT, the Look AHEAD (Action for Health 
in Diabetes) trial, conducted in the USA, where 5145 overweight or obese patients with type 2 
diabetes were randomized to either an intensive lifestyle intervention (i.e., a combination of diet, 
physical activity, and behavioral strategies, with frequent meetings during a year), or to an 
intervention of Diabetes Support and Education (i.e., 3 group sessions in a year). At post-
intervention, the intensive lifestyle program was associated with significantly greater weight loss, 
improved cardiometabolic risk profiles, reduced medication need to control CVD factors, reduced 
mortality rate, improved hbA1c, glycemic control, blood pressure, and lipid profile (Wing et al., 
2010). 
While the evidence for the efficacy of each individual component of lifestyle interventions 
in preventing type 2 diabetes is still limited (Hemmingsen et al., 2017), studies are in agreement 
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that comprehensive multicomponent lifestyle interventions can be effective in the prevention or 
delay of type 2 diabetes in high-risk individuals, with results sustained for several years following 
conclusion of the intervention (Schellenberg et al., 2013).  
Despite these encouraging data, there is substantial variability in response to treatment. The 
main challenge is related to the maintenance of results in the long-term (Curioni & Lourenço, 2005; 
Katz, 2005). In fact, even patients that initially obtain a clinically significant weight loss often 
relapse and regain weight, with a consequent worsening of glycemic control. For example, in the 
Look AHEAD trial, percentage weight lost went from 8.6% at 1 year to 4.7% at 4 years after the 
intensive lifestyle intervention and worsening in all other outcomes was observed over time. 
Ultimately, at a median follow-up of 9.6 years the study was interrupted because the intervention 
was not shown to reduce the incidence of CVD events (Wing et al., 2010). Thus, there is a 
demonstrated need for comprehensive interventions that are effective in both the short and long-
term, for both weight loss and diabetes. 
 
1.3.2 Medications 
Pharmacotherapy in type 2 diabetes is generally indicated for individuals with type 2 
diabetes presenting with a hbA1c > 7.5%, although patients between 7 and 7.5% may be trialed on 
3-6 months of lifestyle changes in diet and physical activity if they are highly motivated to avoid 
pharmacologic treatment (American Diabetes Association, 2020d; Davies et al., 2018). 
The most common oral drug prescribed is metformin as it is effective in lowering hbA1c, 
may result in modest weight loss, has minimal side effects including no risk of hypoglycemia, and 
is widely available and low in cost. A variety of other oral diabetes medications are commonly 
prescribed and may be necessary if metformin is contraindicated or is not sufficient to reach target 
hbA1c. Examples include the GLP-1 receptor agonists, DPP-4 inhibitors, SGLT2 inhibitors, 
sulfonylureas, meglitinides, and thiazolidinediones. These medications are often less desirable than 
metformin as initial therapy due to increased cost as well as adverse effects such as weight gain 
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(sulfonylureas, meglitinides), hypoglycemia (sulfonylureas, meglitinides), and urinary tract 
infections (SGLT2 inhibitors) (American Diabetes Association, 2020d; Davies et al., 2018). 
If target hbA1c cannot be achieved with lifestyle modification and oral hypoglycemics 
alone, insulin may be indicated. This often requires a complex regimen of both short and long-
acting insulin combined with frequent blood sugar monitoring through self-administered needle-
stick testing. Patients are subject to side effects from insulin of weight gain and hypoglycemia, and 
access can be a challenge for patients in countries without robust public healthcare infrastructures 
(American Diabetes Association, 2020a). 
 The use of medication for weight loss is usually considered in combination with lifestyle 
modification and only in patients with a BMI ≥ 27 kg/m2 with weight-related comorbidities or a 
BMI ≥ 30 kg/m2 without comorbidities, who failed to achieve clinically significant weight loss by 
lifestyle modification alone. Weight loss medications currently prescribed include orlistat, which 
interferes with lipid digestion, the combination sympathomimetic/anticonvulsant phentermine-
topiramate, the combination antidepressant/opioid antagonist bupropion-naltrexone, and the 
individual sympathomimetics phentermine, benzphetamine, phendimetrazine, and diethylpropion. 
Some drugs such as the oral diabetes medications metformin and liraglutide have minor effects on 
weight loss but may be indicated for weight loss in patients who would otherwise benefit from 
those medications to treat diabetes (Apovian et al., 2015). 
Although the data is heterogeneous, short-term (6-12 months) clinical trials investigating the 
efficacy of pharmacology for obesity have shown an association between orlistat, bupropion-
naltrexone, phentermine-topiramate, and liraglutide and achieving at least 5% weight loss at 52 
weeks, with phentermine-topiramate and liraglutide showing the greatest efficacy (Khera et al., 
2016). A previously approved drug, the serotonergic medication lorcaserin, has been discontinued 
in the USA due to an associated increased risk of developing cancer (Sharretts et al., 2020). 
 20  
Nevertheless, the use of pharmacotherapy for weight loss is still controversial due to 
unpleasant side effects and limited data on efficacy compounded by low adherence, small effect 
sizes, and high rate of weight regain after discontinuation (Kushner, 2014). 
 
1.3.3 Surgery 
Weight loss surgery is usually suggested for patients who are not able to achieve weight loss 
with lifestyle interventions and pharmacotherapy alone, with a BMI ≥ 40 kg/m2, a BMI between 35 
and 39.9 kg/m2 with one or more serious comorbidities, including type 2 diabetes, or in some cases 
a BMI between 30 and 34.9 kg/m2 with uncontrollable type 2 diabetes (Brito et al., 2017). As a 
result, many overweight/obese individuals with type 2 diabetes may be indicated for such a 
procedure. 
 There are various surgical procedures currently accepted, with the most common 
procedures being sleeve gastrectomy and Roux-en-Y gastric bypass. They generally consist of 
directly or indirectly reducing available stomach volume to limit food intake, thus acting as a form 
of calorie restriction (Brito et al., 2017). 
Weight loss surgery results in significantly greater weight loss, glycemic improvement, 
reduction of cardiometabolic risk factors, and overall mortality reduction than both comprehensive 
lifestyle interventions and medication (Courcoulas et al., 2014; Dixon, 2009; Halperin et al., 2014). 
An average of 20% to 40% weight loss has been observed, and studies have shown that weight loss 
surgery can reduce the incidence of new cases of type 2 diabetes, result in the resolution of some 
cases of type 2 diabetes, and lead to significant improvements in type 2 diabetes, dyslipidemia, and 
hypertension (Carlsson et al., 2012; Lautz et al., 2011). While most patients will regain some 
weight over the long-term, treatment failure defined as weight regain to within 5% of baseline 
weight has been observed at a rate of 3.4-30.5% within 4 years of operation depending on the 
procedure, with Roux-en-Y being the most effective and adjustable gastric banding the least 
(Maciejewski et al., 2016). 
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Major limitations to the implementation of these procedures include severe postoperative 
complications, limited accessibility, and maintenance of results. Severe postoperative complications 
can vary based on the specific surgical procedure utilized, but commonly include wound infections, 
dumping syndrome, bacterial overgrowth, stomal stenosis, marginal ulceration, and gallstones 
(Lautz et al., 2011). These procedures are therefore only indicated for patients that meet strict 
criteria and are not indicated for all patients with overweight/obesity. Accessibility is another major 
limiting factor in the adoption of weight loss surgery, as it is expensive and requires significant 
financial resources which limits its applicability in resource-poor settings such as the developing 
world (Wolfenden et al., 2019). Prescribing bariatric surgery therefore requires a thorough risk-
benefit analysis, and may not be suitable for many patients who are candidates for less invasive 
weight-loss and glycemic control strategies (Kushner, 2014).  
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Chapter 2: PSYCHOSOCIAL VARIABLES IN TYPE 2 DIABETES 
 
2.1 Psychological distress 
Psychological distress is common among patients with type 2 diabetes and, whether 
reaching the threshold for a clinical disorder or presenting subclinically, has been linked to a variety 
of adverse health outcomes (American Diabetes Association, 2017a; Dennick et al., 2015; Khaledi 
et al., 2019). 
Living with a diagnosis of diabetes can be difficult because it often requires many changes 
in lifestyle and self-care behaviors such as frequent medication use, dietary changes, increases in 
physical activity, and monitoring blood glucose, all combined with the distress associated with the 
disease and its complications (Dennick et al., 2017). Moreover, these changes can affect the social 
life of patients who may have to manage difficult interpersonal situations, like finding a balance 
between social expectations and medical requirements when eating with other people (Browne et 
al., 2013; Dennick et al., 2017). Individuals with diabetes may also face social stigma related to 
their condition, with commonly reported experiences including others blaming them for causing 
their condition, negative stereotypes, discrimination, and restricted opportunities in life (Browne et 
al., 2013). 
When associated with overweight and obesity other factors come into play. For example, it 
is common for people with excessive weight to be dissatisfied with their body image and experience 
discrimination because of it, particularly in the case of severe obesity, and this can have a 
significant impact on the individual’s self-esteem (Sarwer & Polonsky, 2016). Moreover, obesity is 
often associated with significant physical and occupational dysfunction that can have a negative 
impact on health-related quality of life (Sarwer & Polonsky, 2016). 
All of this can have a major impact on mental health and predispose to the development of 
various forms of psychological distress in those with type 2 diabetes such as diabetes-related 
distress, depression, and anxiety (Feng & Astell-Burt, 2017). 
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2.1.1 Diabetes-related distress 
The construct of diabetes-related distress was introduced by Polonsky et al. (1995) to 
specifically address the emotional distress of living with diabetes and the burden of self-care. 
Symptoms of diabetes-related distress can include feeling burned out or overwhelmed by the 
demands of self-care, fear of diabetes complications, discouragement and lack of motivation, and 
feelings of anger, guilt, frustration, denial, and loneliness (Kreider, 2017; Polonsky et al., 1995). 
This array of emotions can result in poor self-care behaviors and lack of adherence to diabetes 
regimens (Kreider, 2017; Polonsky et al., 1995). The most common scales to assess diabetes-related 
distress are the Problem Areas in Diabetes (PAID) scale (Polonsky et al., 1995) and the Diabetes 
Distress Scale (DDS) (Polonsky et al., 2005), encompassing areas related to treatment regimen, 
diet, complications, interpersonal relationships, and relationships with health care professionals 
(Dennick et al., 2017).  
Diabetes-related distress must be distinguished from other psychological disorders like 
depression, because even if the constructs of diabetes-related distress and depression are strongly 
correlated and partially overlapping, diabetes-related distress encompasses experiences and 
challenges that are uniquely related to patients with diabetes (Snoek et al., 2015). In a longitudinal 
study on patients with type 1 and type 2 diabetes, only 4.5% of the sample screened positive for 
both depression and diabetes-related distress, compared to 10% for depression and 13% for 
diabetes-related distress considered alone. On the other hand the correlation between diabetes-
related distress and depression is evidenced by an apparent bi-directional association, with one 
predicting the other after one year (Snoek et al., 2012). Similarly, in another prospective study, 
improvements in depressive symptoms among patients with diabetes were independently predicted 
by improvements in diabetes-related distress (Reimer et al., 2017). 
The prevalence of diabetes-related distress varies across studies based on the definition 
used. According to one systematic review and meta-analysis (Perrin et al., 2017), the prevalence of 
diabetes-related distress as assessed by both the PAID (Polonsky et al., 1995) and DDS (Polonsky 
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et al., 2005) scales was 36% among patients with type 2 diabetes. The most common dimension of 
diabetes-related distress is that related to emotional burden (Gahlan et al., 2018; Parsa et al., 2019), 
followed by distress related to diabetes regimen, interpersonal relationships, and the relationship 
with the physician (Gahlan et al., 2018). 
A higher risk of developing diabetes-related distress among patients with type 2 diabetes has 
been associated with a variety of factors in various studies. These included sociodemographic 
characteristics (i.e., being female, lower income, and lower education), medical variables (i.e., past 
and current depression, diabetes complications, use of insulin, shorter diabetes duration, excessive 
weight, and poor control of glycemic levels, lipid profile, and blood pressure), lifestyle-related 
factors (i.e., poor diet, and lack of physical activity), more stressful life events, and chronic stress 
(Alvani et al., 2020; Azadbakht et al., 2020; Fisher et al., 2009; Gahlan et al., 2018; Parsa et al., 
2019; Perrin et al., 2017; Islam et al., 2017). 
At the same time, the presence of diabetes-related distress can have a negative impact on 
self-care behaviors and health outcomes. Accordingly, high levels of diabetes-related distress have 
been associated with lower levels of self-efficacy and poorer adherence to medication, diet, and 
physical activity regimens, which in turn compromise glycemic control and increase the risk of 
microvascular complications and all-cause mortality (Aikens, 2012; Ascher-Svanum et al., 2015; 
Darwish et al., 2018; Fisher et al., 2008; Fisher et al., 2007; Gahlan et al., 2018). In another 
example, a study by Indelicato et al. (Indelicato et al., 2017) found that both diabetes-related 
distress and low self-efficacy were associated with high levels of hbA1c. If not specifically 
addressed, diabetes-related distress can also interfere with participation in and outcomes of 
educational and self-management interventions (Fonda et al., 2009; Weinger & Jacobson, 2001).  
 
2.1.2 Depression 
Compared to the general population, the prevalence of depression is almost twice as high in 
patients with type 2 diabetes (Anderson et al., 2001; Roy & Lloyd, 2012). Depression is a 
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heterogeneous condition characterized by the combination of a variety of symptoms (Goldberg, 
2011). According to the DSM-5 (American Psychiatric Association, 2013), a diagnosis of major 
depressive disorder is made when at least five symptoms are present for at least two weeks and are 
associated with significant distress and/or impairment. These five symptoms must include either 
depressed mood or anhedonia, in addition to any combination of appetite/weight changes, sleep 
changes, lack of energy, psychomotor agitation or retardation, feelings of worthless or guilt, 
difficulty concentrating, and suicidality. According to a recent systematic review and meta-analysis 
of observational studies, almost one in four adults with type 2 diabetes have a comorbid depressive 
disorder (Khaledi et al., 2019). 
Depressive symptoms can also occur at a subsyndromal level in patients with type 2 
diabetes (Darwish et al., 2018). Specifically, symptoms of depression that do not meet the criteria 
for a fully diagnosed depressive disorder in terms of frequency, severity, and/or duration are usually 
referred to as subthreshold depression (Juruena, 2012). Minor depression, for example, is a 
condition that has been defined in the DSM-IV-TR (American Psychiatric Association, 2000) as 
characterized by at least two, but less than five, depressive symptoms, of which one must be either 
depressed mood or anhedonia, with no history of another depressive disorder. Subthreshold 
depression is more common than major depression among patients with diabetes (Albertorio-Diaz 
et al., 2017). In a prospective study among patients with type 2 diabetes, for example, almost half of 
participants reported at least one episode of subthreshold depression within five years (Schmitz et 
al., 2014). 
A variety of factors have been associated with a greater risk of developing depression 
among patients with type 2 diabetes. These factors are similar for major and minor depression and 
include socio-demographic characteristics (i.e., being female, being unmarried, younger age, and 
lower education), medical and psychological variables (i.e., poor glycemic control, obesity, physical 
disability, family history of diabetes, diabetes complications and other medical comorbidities, 
insulin therapy, history of major depression, diabetes-related distress, and lack of physician 
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support), and lifestyle-related variables (i.e., lack of physical activity and smoking) (Alzahrani et 
al., 2019; Bahety et al., 2017; El Mahalli, 2015; Kamrul-Hasan et al., 2019; Katon et al., 2004; 
Khan et al., 2019; Lloyd et al., 2018; Mathew et al., 2013). Duration of diabetes is another factor 
that has been associated with the development of depression (Alzahrani et al., 2019; Bahety et al., 
2017; Kamrul-Hasan et al., 2019). Specifically, the risk of developing depression appears to be the 
highest soon after a diagnosis of diabetes is made and then later in the course of the disease with the 
development of complications (Darwish et al., 2018). Moreover, being overweight, having poor 
physical functioning, and showing low levels of physical activity were significant predictors of 
depression in a sample of elderly patients with diabetes (Chen et al., 2019). 
Similarly to what has been observed for diabetes-related distress, depression can have a 
negative impact on self-care behaviors and health outcomes. Specifically, patients with type 2 
diabetes who are also depressed show lower self-efficacy and poorer self-care behaviors related to 
diet, physical activity, adherence to medication, and smoking cessation. This can result in poor 
glycemic control, poor lipid profile, higher blood pressure, microvascular complications, 
macrovascular complications (i.e., coronary artery disease and stroke), poor health-related quality 
of life, work absenteeism, and all-cause mortality (Brown et al., 2016; Gahlan et al., 2018; Katon, 
2010; Mukherjee & Chaturvedi, 2019). When comorbid, depression can also worsen diabetes-
related distress, and both act in tandem to negatively affect glycemic control (Snoek et al., 2015). 
Even if less severe than a frank depressive disorder, subthreshold depression has been associated 
with impaired health-related quality of life and poor glycemic control (Lustman et al., 2000; 
Schmitz et al., 2014). Its presence also increases the risk of developing a major depressive disorder, 
diabetes-related complications, work and functional disability, and all-cause mortality (Coleman et 
al., 2013; Lee et al., 2019; Lin et al., 2010).  
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2.1.3 Anxiety 
Another form of psychological distress that is commonly experienced by patients with type 
2 diabetes is anxiety. Symptoms of anxiety are usually experienced as feelings of worry and a state 
of hyperarousal with respect to a future circumstance. These symptoms are often associated with 
avoidance behaviors and somatic complaints (e.g., accelerated heartbeat, increased sweating, 
gastrointestinal symptoms, headache, etc.) (Bickett & Tapp, 2016). In patients with diabetes, 
common sources of anxiety may be related to not being able to control hyperglycemia, use of 
insulin injections, and the health consequences of the disease (American Diabetes Association, 
2017a). While temporary states of anxiety are considered normal, clinically significant and more 
persistent anxiety can be debilitating. Similarly to depression, anxiety symptoms can be subclinical 
when not meeting the threshold for a specific disorder. Compared with depression and diabetes-
related distress, anxiety disorders are less persistent and tend to be more episodic (Fisher et al., 
2008). 
The prevalence of both anxiety symptoms and diagnosed disorders are higher among 
patients with type 2 diabetes than in the general population (Fisher et al., 2008; Smith et al., 2013), 
with the prevalence of anxiety symptoms that do not fulfil the criteria for an anxiety disorder 
estimated to be between 15% and 73%, and that of anxiety disorders to be between 1.4% and 15.6% 
(Smith et al., 2013). More specifically, in a large multinational study among patients with type 2 
diabetes, the most common anxiety disorders were generalized anxiety disorder and panic disorder, 
with a prevalence of 8.1% and 5.1%, respectively (Chaturvedi et al., 2019).   
Risk factors that predispose to the development of anxiety in patients with diabetes include 
being female, younger age, low socioeconomic status, longer duration of diabetes, poorer glycemic 
control, diabetes complications, and chronic comorbidities (Chaturvedi et al., 2019; Collins et al., 
2009; Fisher et al., 2008; Grigsby et al., 2002; Hermanns et al., 2005). 
 Anxiety symptoms, whether clinical or subclinical, have a been associated with a number of 
adverse outcomes in patients with diabetes. These include poor adherence to dietary modification, 
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physical activity, and smoking cessation, poor glycemic control, greater risk for diabetes-related 
complications such as stroke, and poor quality of life (Anderson et al., 2002; Collins et al., 2009; 
Dong et al., 2019; dos Santos et al., 2014; Tsai et al., 2016; Turkat, 1982). Moreover, anxiety can 
predict fear of insulin injections and hypoglycemia, that in turn are associated with the avoidance of 
important self-care behaviors like blood glucose monitoring and appropriate increase of insulin 
dosing (Wild et al., 2007). 
 
2.1.4 Other psychosocial variables  
Although less studied, other psychosocial variables have been investigated with respect to 
their prevalence and impact in diabetes, and have been shown to negatively affect self-management 
and health outcomes.  
Sleep problems are commonly experienced by patients with type 2 diabetes, with up to 50% 
reporting poor sleep quality (Da Cunha et al., 2008). The presence of poor sleep quality, especially 
if associated with anxiety, has shown to have a negative impact on glucose control and quality of 
life (Dong et al., 2020; Zhu et al., 2018). 
Somatization, interpersonal sensitivity, and anger-hostility were all significantly more 
common among patients with type 2 diabetes than non-diabetic controls (Dogan et al., 2019). 
Prospective and cross-sectional studies have shown that hostility is associated with poor glucose 
control, insulin resistance, and greater systemic inflammation in response to acute stress, with an 
increased risk of cardiovascular disease and mortality (Elovainio et al., 2011; Hackett et al., 2015; 
Jonasson et al., 2019; Todaro et al., 2005). 
 Finally, the prevalence of dysfunctional eating behaviors among patients with diabetes is 
highly variable across studies, ranging from less than 5% to 20% (Mannucci et al., 2002; 
Papelbaum et al., 2005). Binge eating disorder is the most common eating disorder among patients 
with type 2 diabetes and is often related to an increase in anxiety (Papelbaum et al., 2005). 
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Dysfunctional eating behaviors can also be associated with poor metabolic control (Mannucci et al., 
2002). 
 
2.1.5 Psychological interventions for distress 
In light of the high prevalence and negative health outcomes of psychological distress, 
current guidelines recommend integrating standard diabetes care with regular psychological 
assessment and treatment (American Diabetes Association, 2017a).   
Numerous psychological interventions specifically designed to address psychological 
distress in patients with diabetes have been developed and tested. Due to high heterogeneity across 
studies, it is difficult to draw conclusions on the effect of a specific type of intervention. In fact, 
except for a few meta-analyses that specifically focused on cognitive behavioral therapy and 
mindfulness-based cognitive therapy (Tovote et al., 2014; Uchendu & Blake, 2017; Wang et al., 
2017), most meta-analyses do not differentiate between different types of psychological 
interventions, including a variety of cognitive and emotion-focused interventions (e.g., social 
support, stress management and coping skills training, motivational interviewing, etc.). Not only 
were these interventions different with respect to the specific techniques utilized, but they also 
differed in duration, intensity (e.g., number of sessions and frequency), setting (e.g., individual vs. 
group), and method of delivery (e.g., in person vs. telehealth) (Mathiesen et al., 2019). 
As to the effect of these interventions on measures of psychological distress, most meta-
analyses indicated that psychological interventions can have a significant effect on measures of 
depression and/or anxiety (Baumeister et al., 2014; Markowitz et al., 2011; Mathiesen et al., 2019; 
Tovote et al., 2014; Uchendu & Blake, 2017; van der Feltz-Cornelis et al., 2010; Wang et al., 2017). 
Effects on diabetes-related distress have been mixed, with two meta-analyses showing significant 
improvements (Mathiesen et al., 2019; Tovote et al., 2014), one showing mixed findings (Uchendu 
& Blake, 2017), and another showing no effect (Chew et al., 2017). Mathiesen et al. (2019) found 
that better results in diabetes-related distress were observed when psychosocial interventions 
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included motivational interviewing, were intense, and were performed in an individual rather than 
group setting. 
Since various forms of psychological distress have been shown to have a negative impact on 
self-care behaviors and health, it has been hypothesized that interventions targeting a reduction in 
psychological distress may result in better behavioral and health-related outcomes (Mathiesen et al., 
2019). Measures of glycemic control such as hbA1c have been the most commonly assessed 
outcomes, but results have been mixed and inconclusive. For example, a significant but small and 
temporary effect from psychological interventions was found on measures of glycemic control in 
two meta-analyses (Chew et al., 2017; Uchendu & Blake, 2017), while no effect or mixed results 
were reported in another four meta-analyses (Baumeister et al., 2014; Markowitz et al., 2011; 
Mathiesen et al., 2019; Tovote et al., 2014). In Mathiesen et al. (2019), psychosocial interventions 
that were more intensive were associated with greater improvements in hbA1c. Other studies found 
no significant effect of psychological interventions in improving quality of life and all-cause 
mortality (Chew et al., 2017; Mathiesen et al., 2019). Chew et al. (2017), in their meta-analysis, 
found that psychological interventions for distress could significantly improve self-efficacy for up 
to 12 months of follow-up. Data on the effect of psychological interventions on other health-related 
outcomes like weight loss are still limited and preliminary. As previously mentioned, weight loss is 
an important outcome for patients with diabetes who are also overweight or obese, and the presence 
of psychological distress has been shown to interfere with intervention participation and benefits 
(Fonda et al., 2009; Weinger & Jacobson, 2001). In a systematic review by Ismail et al. (2004), an 
intervention of cognitive behavioral therapy was shown to be more effective than control (i.e., usual 
care, education, wait list, and attention control) in improving psychological distress, but no effect 
was seen on weight. Thus, there remains a need for interventions effective both in reducing 
psychological distress and improving physiological outcomes in both diabetes and weight loss. 
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2.2 Psychological well-being  
2.2.1 Definition 
For a long time, Western medicine has been characterized by a reductionist approach that 
considers health to be merely the absence of disease and defines it exclusively by physical 
parameters (Tinetti et al., 2004). The WHO’s definition of health as a “state of complete physical, 
mental, and social well-being, not merely the absence of disease or infirmity” (World Health 
Organization, 1984) has had important implications for the development of many national health 
care systems, bringing about a shift from focusing purely on the treatment and prevention of disease 
to actively promoting elements of positive health (Leonardi, 2018).  
In keeping with this trend, there has been a growing research interest in the concept of well-
being as not simply the absence of mental illness or the opposite of psychological distress, but as an 
independent dimension (Ryff & Singer, 1998). Although well-being and distress are inversely 
correlated (Rafanelli et al., 2000), the contribution of well-being to both mental and physical health 
can be independent from that of distress (Ryff, 2014).  
In psychology there are two main perspectives on well-being: hedonic and eudaimonic 
(Huta & Waterman, 2014; Ryan & Deci, 2001). Within each of these perspectives, multiple models 
of well-being have been developed. Hedonic well-being has been most commonly referred to as 
subjective well-being (SWB) and described as happiness, pursuit of pleasure, and life satisfaction 
(Diener et al., 1999), while eudaimonic well-being has been generally defined as fulfilling one’s 
potential and having a sense of purpose and meaning in life (Ryff, 1989). Huta and Waterman 
(2014) identified 11 models with comprehensive measures of eudaimonic well-being. Among these, 
the Jahoda-Ryff model (Jahoda, 1958; Ryff, 1989) of psychological well-being (PWB) is the most 
commonly used in research. According to this model, PWB is characterized by 6 distinct but 
interrelated dimensions: 1) autonomy, 2) environmental mastery, 3) personal growth, 4) positive 
relations with others, 5) purpose in life, and 6) self-acceptance. More recently, the concept of 
euthymia has been proposed as an integrative construct that includes positive affect, the 6 
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dimensions of PWB, flexibility (i.e., balance and integration of psychic forces), consistency (i.e., a 
unifying outlook on life which guides actions and feelings accordingly), and resilience and 
tolerance to anxiety and frustration (i.e., resistance to stress) (Fava & Guidi, 2020). The concept of 
euthymia has also been defined by Fava and Bech (2016) as: 1) not having a diagnosis of a mood 
disorder and only experiencing negative emotions that are transitory, circumscribed, and with no 
significant impact on everyday life; 2) feeling cheerful, calm, active, interested in things, and 
having a restful sleep; and 3) showing flexibility, consistency, and resistance to stress.  
The concept of “diabetic euthymia” or “euthymic diabetes” as a state of optimal mood has 
been recently introduced as a target in diabetes care, suggesting that interventions for diabetes 
should focus on promoting a sense of euthymia rather than solely on avoiding diabetes-related 
distress (Kalra et al., 2018), in this sense being analogous to the pursuit of psychological well-being 
in other disciplines. 
 
2.2.2 Health-related consequences 
Just as psychological distress has been shown to result in worse self-care behaviors and health 
outcomes, various well-being constructs have been associated with better health outcomes in 
different medical conditions (Ryff, 2014). More specifically, different measures of subjective and 
psychological well-being have been shown to affect physical health on an immune, endocrine, and 
cardiovascular level (Diener et al., 2017; Ryff, 2014), showing a protective role against 
cardiovascular and metabolic conditions (Boehm & Kubzansky, 2012; Boylan & Ryff, 2015; Sin, 
2016). Data from longitudinal studies have also indicated that higher levels of well-being are 
associated with better life expectancy and lower risk to experience disability or chronic disease 
(Kim et al., 2017; Paganini-Hill et al., 2018; Zaninotto & Steptoe, 2019). Among patients with 
diabetes, higher levels of well-being have been associated with better glycemic control, greater 
adherence to diet, exercise, blood glucose monitoring, and medication, and with a lower risk of 
chronic complications and all-cause mortality (Al-Khawaldeh et al., 2012; Judith Tedlie Moskowitz 
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et al., 2008; Papanas et al., 2010; Yi et al., 2008). Moreover, among individuals from the general 
population, well-being may reduce the risk of developing type 2 diabetes over up to 13 years of 
follow-up (Boehm et al., 2015; Okely & Gale, 2016; Poole et al., 2020). 
Health behaviors appear to mediate the relationship between well-being and health. 
Specifically, higher levels of subjective and psychological well-being have been associated with 
better diet, more exercise, and improved sleep (Diener et al., 2017; Ryff, 2014). In patients with 
diabetes, for example, those with higher levels of self-efficacy and optimism have been shown to 
have higher quality of life and more active coping behaviors that, in turn, have a significant effect 
on hbA1c reduction (Rose et al., 2002).  
Finally, well-being appears to have a buffering effect on the impact of psychological distress on 
health behaviors (Steptoe et al., 2008; Tighe et al., 2016). For example, in patients with type 2 
diabetes, Yi et al. (Yi et al., 2008) showed that resilience had a buffering effect on the worsening in 
hbA1c and self-care behaviors in patients experiencing diabetes-related distress. Higher levels of 
well-being may impact the way people interpret stressful situations and promote more efficient 
coping strategies that, in turn, reduce the adverse health consequences of stressor exposure 
(Pressman & Cohen, 2005).  
 
2.2.3 Well-being interventions 
Considering the positive effect that a variety of constructs of well-being have on distress, 
self-efficacy, self-care behaviors, and health outcomes, the application of interventions that 
specifically address and promote different aspects of well-being is warranted among patients with 
type 2 diabetes (Massey et al., 2019). In addition, well-being interventions are broadly applicable to 
patients that do not necessarily fulfill the criteria for a psychiatric disorder but show significant 
symptoms of distress (Fredrickson, 2001).  
Even if well-being interventions have been shown to improve both psychological and health 
outcomes in medical conditions such as cardiovascular disease, hypertension, and HIV (Moskowitz 
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et al., 2017; Ogedegbe et al., 2012; Peterson et al., 2012), little attention has been paid to the effect 
of well-being interventions in patients with diabetes. The first systematic review on the 
psychological and physical health effects of well-being interventions in patients with diabetes has 
been published recently by Massey et al. (2019). According to this review, most studies have 
implemented a mindfulness-based intervention and shown a significant effect in improving levels of 
depression and well-being. Other interventions have included positive psychology interventions, 
acceptance and commitment therapy, resilience-based interventions, and interventions to promote 
emotional intelligence, positive self-concept, and self-efficacy. Data on the effects of these 
interventions in improving psychological distress and well-being have been reported in a small 
number of studies showing mixed results (Massey et al., 2019). Data on the effect of well-being 
interventions on health-related outcomes, such as hbA1c, glucose monitoring, medication 
adherence, lipid profile, self-management, physical activity, and weight are still preliminary with 
only a minority of studies reporting on this (Massey et al., 2019). Regarding weight, only three 
studies implementing mindfulness-based interventions have considered it as an outcome, and only 
one of these studies showed a significant reduction in weight over time after a mindful eating 
intervention, but the effect was not significantly different from that of an intervention of diabetes 
self-management reduction (Miller et al., 2012). 
Developing and testing the application of well-being interventions among patients with chronic 
medical conditions like diabetes is still a growing field and other options are being considered. 
Among these, Well-Being Therapy (WBT) is an innovative short-term psychotherapeutic strategy 
that, unlike many well-being interventions, is not aimed at maximizing positive emotions and 
cognitions but rather at achieving a state of euthymia or balance among different areas of well-
being (Fava, 2016a). Initially developed to improve residual symptoms and increase levels of 
recovery among patients with depression, early evidence is suggesting its application among 
patients with chronic medical conditions (Benasi et al., 2019; Fava, 2016b). 
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Chapter 3: EXPERIMENTAL STUDY 
 
3.1 Rationale 
Overweight and obesity are major risk factors for the development of type 2 diabetes  
(World Health Organization, 2020a, 2020c). The prevalence of type 2 diabetes increases linearly 
with BMI (Nguyen et al., 2011) and about 65-80% of diabetic patients are overweight or obese 
(World Health Organization, 2020a, 2020c), presenting a greater risk for mortality and serious 
health complications (Wing, 2001). Given the significant increase in the past three decades in the 
prevalence of both type 2 diabetes and obesity (Zimmet et al., 2014), it is of particular importance 
to provide diabetic patients with effective weight loss interventions (World Health Organization, 
2020a, 2020c). Therefore, behavioral lifestyle interventions for weight loss have a pivotal role in 
diabetes management. 
Several psychosocial factors have been found to have an impact on individual vulnerability, 
course, and outcome of medical disease (Fava et al., 2017), and their presence can interfere with 
behavioral change (Geiker et al., 2018). Specifically, psychological distress is common among 
patients with type 2 diabetes (Dennick et al., 2015; Khaledi et al., 2019) and has been linked to poor 
health behaviors and a variety of adverse clinical outcomes (Dirmaier et al., 2010; Dong et al., 
2020; Guerrero Fernández de Alba et al., 2020). On the other hand, various indicators of 
psychological well-being have been associated with better health outcomes across numerous 
medical conditions (Ryff, 2014). 
Psychological interventions for the promotion of well-being have shown some promise in 
reducing levels of distress and improving health-related outcomes. However, only a few studies are 
available on this topic and the data are still preliminary (Massey et al., 2019), which speaks to the 
need of investigating novel methods for improving well-being and other psychological parameters 
to improve physiological health outcomes. Well-being therapy (WBT) (Fava, 2016a) is an 
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innovative short-term psychotherapeutic strategy aimed at achieving a state of euthymia or balance 
within psychological dimensions of well-being according to the model originally developed by 
Jahoda (1958). To date, WBT has been effective in enhancing recovery in depression and 
generalized anxiety disorder, modulating mood in cyclothymic disorder, and promoting 
mechanisms of resilience and psychological well-being in an educational setting with children and 
adolescents. Preliminary data suggest its potential role in managing the challenges related to 
chronic medical conditions and in promoting healthy attitudes and behaviors (Benasi et al., 2019; 
Fava, 2016b), which suggests it may have promise when applied to weight loss in the context of 
type 2 diabetes. 
 
3.2 Aims and Objectives 
The main aim of this study was to develop and evaluate a 4-month combined well-being and 
lifestyle intervention for weight loss and distress reduction in patients with type 2 diabetes. In 
particular, the study attempted to provide an answer to the following questions: is the 
implementation of a novel combined well-being and lifestyle intervention feasible and acceptable to 
patients; and can a well-being and lifestyle intervention better help patients with type 2 diabetes in 
managing their weight and distress levels compared to a lifestyle intervention alone? 
Specifically, the objectives of the present study were to: 
1. Estimate study feasibility; 
2. Investigate intervention acceptability; 
3. Test the superiority of a combined well-being and lifestyle intervention (WBT-
lifestyle) in promoting changes in measures of weight, psychological well-being, 
psychological distress (primary superiority outcomes), lifestyle, and physiological 
parameters (secondary superiority outcomes), by comparing the outcomes of the 
WBT-lifestyle group to those of a group receiving only the lifestyle intervention 
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(lifestyle alone), at immediate post-intervention and at 6-month post-intervention 
follow-up; 
4. Examine effect size estimates of key outcomes to provide essential data to inform a 
larger superiority trial. 
 
3.3. Hypotheses 
We expected to observe significantly greater improvements in measures of weight, 
psychological well-being and distress, lifestyle, and physiological parameters in the group of 
participants receiving the combined WBT-lifestyle intervention than in those receiving the lifestyle 
alone intervention at both post-intervention and 6-month follow-up. 
 
3.4 Methods  
3.4.1 Research design and procedures 
This study is a multicenter, parallel-arm, assessor-blinded, randomized controlled trial. 
Participants were recruited from March 2018 to June 2019 at two outpatient endocrinology clinics 
in northern Italy, the Servizio di Endocrinologia e Diabetologia of Bufalini Hospital in Cesena and 
the Struttura Semplice di Endocrinologia e Metabolismo of Oglio Po Hospital in Casalmaggiore, a 
town in the Province of Cremona. Both clinics deal with the diagnosis and treatment of adult 
patients with endocrine and metabolic disorders, including type 2 diabetes.  
Physicians and nurses at both sites were given a brief checklist of main eligibility criteria 
and were asked to screen consecutive patients attending the clinic during the enrollment period. 
Patients who appeared to be eligible were introduced to the study and referred to one of the study 
researchers for a more in-depth screening evaluation. Eligibility was determined based on medical 
chart review and patients’ self-reported information using an ad hoc checklist. The Structured 
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Clinical Interview for DSM-5, Clinical Version (SCID-5-CV) (First et al., 2016) was used to assess 
for the presence of psychiatric diagnoses. 
Eligible participants who consented to participate in the study were randomly assigned to 
either the combined WBT-lifestyle intervention or the lifestyle alone intervention with an allocation 
ratio of 1:1. The possibility of being randomized to one of two different interventions was made 
clear to participants during the consent process. The randomization schedule was generated with the 
Random Allocation Software 2.0, a free software program designed to support simple and block 
randomization in parallel group trials. Block randomization with random block sizes was used to 
ensure a balance in sample size across groups while maintaining the unpredictability of the 
randomization process. 
The trial received approval from the Ethics Committee of each clinic, the Comitato Etico 
della Romagna and the Comitato Etico Val Padana. The study was registered on ClinicalTrials.gov 
(NCT03609463). All study participants provided written informed consent. 
 
3.4.2 Participants  
Participants were considered to be eligible and included in the study if they a) were 
overweight (BMI ≥ 25) or obese (BMI ≥ 30), b) adult (18-65 years old), and c) had a diagnosis of 
type 2 diabetes.  
Reasons for exclusion were: 
a) Inability to speak Italian fluently; 
b) Inability to provide informed consent (e.g., cognitive impairment); 
c) Any medical condition that would make participation in the study difficult or unsafe, or 
that is associated with unintentional weight loss or gain (i.e., any cancer, congestive 
heart failure, untreated or unstable hyperthyroidism, kidney failure on dialysis, and 
severe orthopedic disorders);  
d) Untreated, severe, or recently diagnosed (≤ 6 months) mental illness or personality 
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disorder; 
e) History of eating disorders or substance abuse; 
f) Use of appetite suppressants (e.g., sibutramine), lipase inhibitors (e.g., orlistat), or 
dietetic products (e.g., meal replacements, herbs); 
g) Involvement in another weight-loss program, trial, or in any other behavioral 
intervention; 
h) History of weight loss surgery or weight loss surgery scheduled within the year;  
i) Pregnancy or intention to become pregnant within the next year; 
j) Inability to control meal contents (e.g., institutionalized patients). 
 
3.4.3 Interventions  
Participants were involved in the study intervention for up to 16 weeks, for a total of 16 
weekly sessions in the combined WBT-lifestyle group and 12 weekly sessions in the lifestyle alone 
group. Missed sessions were rescheduled until participants completed all sessions of the 
intervention. During the first four weeks, participants in the combined WBT-lifestyle group 
received the well-being intervention in combination with treatment as usual, while those in the 
lifestyle alone group were asked to continue their treatment as usual alone. In the following 12 
weeks, participants in both the combined WBT-lifestyle and the lifestyle alone groups received the 
lifestyle intervention in combination with treatment as usual. 
The same clinical psychologist provided the intervention in both groups in one-to-one 
sessions with each participant. Two psychotherapists with expertise in WBT (Fava, 2016a) offered 
supervision for the implementation of the well-being intervention during the entire duration of the 
study.  
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3.4.3.1 Well-being intervention protocol  
The well-being intervention was delivered in four individua weekly sessions. Each session 
lasted for about an hour and was conducted in-person. All sessions were done in a private room at 
each clinic. 
The intervention has been adapted from the WBT protocol (Fava, 2016a) and it is based on a 
multidimensional model of psychological well-being that was originally developed by Jahoda 
(1958) and further elaborated by Ryff (2014). According to this model, positive mental health is 
characterized by distinct dimensions of psychological well-being, including autonomy, 
environmental mastery, positive relations with others, purpose in life, personal growth, and self-
acceptance. 
The objective of this intervention was to promote a state of euthymia (Fava & Bech, 2016; 
Fava & Guidi, 2020), which corresponds to Jahoda’s sixth criteria “individual’s balance and 
integration of psychic forces” (Jahoda, 1958), in order to reduce psychological distress and motivate 
health attitudes and behaviors. Main features of the intervention included monitoring of 
circumstances of well-being, modification of thoughts and beliefs leading to premature interruption 
of well-being, discussion of dysfunctional dimensions of well-being, and behavioral homework to 
increase exposure to experiences of well-being. 
During the first session, participants were introduced to the structure and focus of the 
intervention. Well-being was described as including both experiences and feelings, but no formal 
definition of well-being was provided at this stage. The relationship between thoughts, emotions, 
and behaviors was explained, with particular reference to the negative impact that dysfunctional 
thoughts and behaviors can have on the ability to experience daily instances of well-being. 
Participants were provided with a structured paper diary and asked to report the circumstances 
surrounding their episodes of well-being, rating them on a scale from 0 (i.e., absence of well-being) 
to 100 (i.e., the most intense well-being that could be experienced). They were also instructed to 
report in the same diary thoughts and behaviors associated with any premature interruption of well-
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being they experienced. The concept of self-therapy was then introduced, to emphasize the active 
role that participants have in promoting their own well-being. At the beginning of each of the 
following sessions, the diary was reviewed and difficulties related to its completion were discussed. 
During the second session, participants were introduced to the concept of optimal experience 
(Csikszentmihalyi & Csikszentmihalyi, 1988) and were asked to report these experiences in the 
diary along with other occurrences of well-being. The concepts of automatic thoughts and 
dysfunctional behaviors (e.g., avoidance behaviors) were also introduced through examples 
available in the diary, and common thinking errors (e.g., all-or-nothing thinking, jumping to 
conclusions, ignoring the evidence, magnifying or minimizing, overgeneralizing, and personalizing) 
were described. Starting from this session, participants were guided into examining the evidence for 
and against their automatic thoughts and were asked to develop alternative ways of thinking and to 
report them in the observer’s column of the diary (see Table 1 for an example of the well-being 
diary). Moreover, activities that were likely to elicit well-being and optimal experiences or 
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July 12th  
 
After years I have the 
opportunity to buy the 
garden furniture that I 
wanted so much. I will 
be able to enjoy the 
garden and spend time 









It was not a necessary 
expense and I should not 






It was not that 
expensive and I have 
always made 
sacrifices in my life. 
For once I can give 
myself and my family 
a gift.  
 
July 26th  
 
My son asked me to 
help him prepare 




The decorations are 
















I really wanted them to 














They are not that bad 
and my son does not 
seem to care too much 
about it. The most 
important thing is that 
we are having a 
pleasant time together.   
 
Source: Benasi, G., Guidi, J., Rafanelli, C., Fava, G.A. (2019). New Applications of Well-Being 
Therapy. Rivista Sperimentale di Freniatria, 1, 87-106. 
 
Finally, during the last two sessions of the intervention, participants were introduced to the 
dimensions of psychological well-being that appeared to be relevant for them. Specifically, either 
high or low levels of each dimension were discussed and the link between these unbalanced 
dimensions and premature interruption of well-being was pointed out (See Table 2 for a description 
of high or low levels of each dimension of psychological well-being). Monitoring of the well-being 
diary and activities continued during the lifestyle intervention. 
 43  
Even if the general structure of the well-being intervention was the same for all participants 
in the combined WBT-lifestyle group, its specific components, such as which dimensions of 
psychological well-being were discussed, which activities were scheduled, and which examples of 
automatic thoughts and dysfunctional behaviors were provided, were all tailored and personalized 
based on the material presented by each participant during the sessions. 
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Table 2: Description of high and low levels of each dimension of psychological well-being 
PWB dimension Low levels Balanced levels High levels 
Autonomy Being overconcerned 
others’ expectations 
and evaluations; 
relying on others’ 
judgement to make 
important decisions. 
Being independent; 
being able to resist 
social pressure; 
regulating behavior 
and self by personal 
standards. 
Being unable to get 
along with other 
people, work in a 
team, and learn from 
others; being unable to 
ask for advice.  
Environmental 
Mastery 
Feeling difficulties in 
managing everyday 
occurrences; feeling 
unable to improve 
things around oneself; 
being unaware of 
opportunities. 
Feeling competent in 
managing the 
environment; making 
good use of 
opportunities; being 
able to choose what is 
more suitable to 
personal needs.  
Looking for difficult 
situations to handle; 
being unable to savor 
positive emotions and 
leisure time; being too 
engaged in work and 
family activities. 
Personal Growth Having a sense of 
being stuck; lacking a 
sense of improvement 
over time; feeling 
bored and uninterested 
in life. 
Having a sense of 
continued 
development; seeing 
oneself as growing and 
improving; being open 
to new experiences. 
Being unable to 
elaborate past negative 
experiences; 
cultivating illusions 
that clash with reality; 
setting unrealistic 
standards and goals. 
Positive Relations with 
Others 
Having few close, 
trusting relationships 
with others; finding it 




concerned about the 
welfare of others; 
understanding the give 
and take of human 
relationships. 
Sacrificing one’s own 
needs and well-being 
for those of others; 
having low self-esteem 
and a sense of 
worthlessness that 
induce excessive 
readiness to forgive. 
Purpose in Life Lacking a sense of 
meaning in life; having 
few goals or aims; 
lacking a sense of 
direction. 
Having goals in life 
and feeling there is 
meaning in the present 




with performance and 
unable to recognize 
failures. 
Self-acceptance Being dissatisfied with 
oneself; being 
disappointed with 
own’s past life; 
wishing to be different. 
Accepting one’s good 
and bad qualities and 
feeling positive about 
one’s past life. 
Having difficulties in 
admitting one’s 
mistakes; attributing 
all problems to the 
fault of others. 
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3.4.3.2 Lifestyle intervention protocol 
The lifestyle intervention was delivered in 12 individual weekly sessions. Four sessions 
(number 1, 4, 8, and 12) were conducted in-person and lasted for about an hour, while the 
remaining sessions were conducted over the phone and lasted for about 30 minutes. All in-person 
sessions took place in a private room at each clinic. 
The intervention was modeled after the Small Changes and Lasting Effects (SCALE) trial 
intervention protocol (Phillips-Caesar et al., 2015; Phillips et al., 2017). It was developed in the 
context of the small change approach (Hill, 2009; Hills et al., 2013) and the Social Cognitive 
Theory (Bandura, 1977). Specifically, it is based on the assumption that, in most people, gradual 
weight gain is due to an “energy gap”, a daily discrepancy between energy intake and energy 
expenditure, and that a gradual weight loss may be achieved by implementing small, sustained 
lifestyle changes that reduce energy intake by about 100-200 kcal a day. Moreover, small changes 
in diet and physical activity, being more feasible to achieve and maintain, may increase feelings of 
self-efficacy and stimulate additional changes.  
The objective of the lifestyle intervention was therefore to help participants gradually lose 
weight by making small changes in their lifestyle. The intervention comprised three key 
components: monitoring of lifestyle changes and weight, goal setting, and problem solving. 
During the first session, participants were introduced to the small change concept and were 
guided in setting their eating and physical activity goals. Participants were presented with a list of 
ten small change eating strategies (Table 3). For the present study the eating strategy “drink plain 
water instead of sweetened drinks” was modified to “drink plain water instead of sweetened and/or 
alcoholic drinks”. After a full discussion of each strategy’s utility and feasibility, participants were 
asked to select a strategy they felt they could accomplish for the following week. The selected 
strategy was defined in terms of “what”, “when”, and “for how long”; for example, a participant 
could decide to “use a smaller plate for lunch, 6 days a week”. There were no pre-defined small 
change strategies for physical activity. Participants were asked to provide information about their 
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current level of physical activity and set a goal that represented an increase in time or intensity. The 
physical activity strategy was defined in terms of “what”, “when”, and “for how long”; for example, 
a participant could decide to “walk for 30 minutes, in the evening, 4 days a week”. Both the eating 
and physical activity strategies needed to represent a change in current habits and be realistic and 
feasible. Finally, participants were instructed to monitor their weight once a week for the entire 
duration of the intervention. 
 






Use a smaller plate for your main meal 
Half of your main meal should be vegetables 
Keep snacks out of sight 
Don’t buy snack food 
Eat a fruit or vegetable before salty or sugary snacks 
Turn off the TV during meals 
Eat breakfast every day 
Take time for your meals (don’t skip a meal) 
Drink plain water instead of sweetened drinks 
Prepare the main meal at home 
Source: Phillips-Caesar et al. (2015). Small Changes and Lasting Effects (SCALE) Trial: the 
formation of a weight loss behavioral intervention using EVOLVE. Contemporary Clinical Trials, 
41, 118-128. 
 
During the following weekly sessions, participants’ adherence to their small change 
strategies was reviewed and facilitators and barriers to goal completion were discussed in order to 
increase participants’ motivation and problem-solving skills. At each session, eating and physical 
activity strategies could be revised, changed, or another goal could be added based on levels of 
adherence to the selected strategies. Participants were encouraged to select one strategy at a time, 
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but there was no limit on the number of strategies that a participant could select during the 12-week 
period. 
 
3.4.3.3 Treatment as usual 
All participants were receiving medications for diabetes or health-related comorbidities and, 
whenever necessary, their physician gave them instructions on how to monitor their glycemic level 
at home (50% of participants were asked to self-monitor glycemic level). At both clinics 
participants were being followed long-term by a team of physicians and nurses and participated in 
regular follow-ups, whose frequency changed depending on their individual health condition (mean 
follow-up of 6.20  2.20 months). Participants also had the opportunity to schedule a meeting with 
a dietician to develop a personalized dietary plan (25.9% of participants were seeing a dietician at 
time of recruitment). 
 
3.4.4 Assessment 
Data were collected for each participant through questionnaires and interviews at baseline 
(T0), post-intervention (T1), and 6-month follow-up (T2). Data were collected in person at each 
clinic for all except six participants who had their 6-month follow-up assessment scheduled in April 
and May 2020. Since this period of time corresponded to the time of mandatory quarantine due to 
the spread of COVID-19, questionnaires and interviews were delivered over the phone for these 
participants. All measures of weight were self-reported: participants were instructed to weigh 
themselves at home wearing light clothing after voiding, and to submit a picture of the 
measurement on the scale. 
Given the nature of the intervention, both the clinical psychologist involved in the 
implementation of the intervention and the participants were not blind. To reduce bias, assessments 
and data analyses were conducted by blinded researchers. 
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3.4.4.1 Baseline assessment 
An ad-hoc questionnaire was used at baseline to collect data on socio-demographic, medical, and 
weight history variables. Data were obtained from chart reviews and participants’ self-reports:  
• Socio-demographic variables included: gender, age, education, marital status, living 
situation, children, and work. 
• Medical variables included: past and present medical/psychiatric disorders, years with 
diabetes, past hospitalizations and surgeries, past psychological/psychiatric interventions, 
presence of cardiovascular risk factors (i.e., hypercholesterolemia, hypertension, smoking, 
and lack of physical activity), family history of medical disorders, and information related to 
diabetes management. 
• Finally, weight history variables included: years overweight/obese and previous and current 
attempts to lose weight. 
The Semi-Structured Interview for the Diagnostic Criteria for Psychosomatic Research – Revised 
version (DCPR-R SSI) (Fava et al., 2017) was also used at baseline. This semi-structured interview 
(SSI) is based on the revised Diagnostic Criteria for Psychosomatic Research (DCPR-R) (Fava et 
al., 2017). The DCPR-R allow the identification of psychopathological conditions often neglected 
by traditional nosography. These criteria have been developed with the intent to operationalize the 
spectrum of manifestations of illness behavior and sub-threshold distress in both psychiatric and 
medical settings, and can be used in addition to the DSM criteria (Cosci & Fava, 2016).  For 
example, using the DCPR-R in addition to the DSM-IV has shown to provide a better assessment of 
the psychological profile of patients in a variety of medical settings (Galeazzi et al., 2004). 
Specifically, the DCPR-R allow the identification of 14 psychosomatic syndromes that are 
subdivided in four major clusters:  
• Stress, including allostatic overload. 
• Personality, including type A behavior and alexithymia.  
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• Illness behavior, including health anxiety, disease phobia, hypochondriasis, thanatophobia, 
illness denial, persistent somatization, conversion symptoms, and anniversary reaction.  
• Psychological manifestations, including demoralization, irritable mood, and functional 
somatic symptoms secondary to a psychiatric disorder. Helplessness and hopelessness are 
further differentiated within demoralization. 
The DCPR-R SSI is organized in a modular structure, with questions referring to the past 6 to 
12 months and answers being recorded in a yes/no response format. The interview has been shown 
to have a good inter-rater reliability, construct validity, and predictor validity for psychological 
functioning and treatment outcomes (Galeazzi et al., 2004). 
In this study, an Italian version of the DCPR-R SSI was used (Fava et al., 2017) to evaluate all 
14 syndromes and offer a better characterization of the study sample. 
 
3.4.4.2 Feasibility and Acceptability 
The study feasibility and acceptability were assessed as: 
• Eligibility rate (i.e., total number of patients eligible out of the total number of patients 
approached); 
• Acceptance rate (i.e., total number of participants enrolled out of the total number of eligible 
patients); 
• Retention rate (i.e., total number of participants who completed the study out of the total 
number enrolled); 
• Total number of sessions rescheduled; 
• Participants’ satisfaction and suggestions for improvement, assessed at the end of the 
intervention by asking the following open-ended questions:  
▪ “Which component of the study did you find to be the most useful?” 
▪ “Which component of the study did you find to be the least useful?” 
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▪ “Which changes have you made in your lifestyle since the beginning of the 
study?” 
▪ “Do you have any suggestions on how to improve the study?” 
 
3.4.4.3 Primary Superiority Outcomes 
Primary efficacy outcomes included measures of weight, psychological distress, and psychological 
well-being: 
• Symptom Questionnaire (SQ) (Benasi et al., 2020; Kellner, 1987) 
The SQ is a 92-item self-rating questionnaire for the assessment of psychological symptoms 
and well-being. The questionnaire is available in two forms: the week form is concerned 
with feelings experienced by the respondent during the past week, while the day form with 
feelings experienced on the day of the test. The questionnaire yields four main scales: 
depression, anxiety, hostility, and somatization. Each scale can be divided into 2 subscales, 
one concerned with symptoms (i.e., depression, anxiety, hostility, and somatization) and one 
with well-being (i.e., relaxation, contentment, friendliness, and physical well-being). 
Answers to each item are dichotomous (yes/no or true/false). Each scale and subscale can be 
scored separately, with scoring ranging from 0 to 17 for the symptom subscales, from 0 to 6 
for the well-being subscales, and from 0 to 23 for the four main scales. The sum of the four 
main scales can also yield a total distress score. Higher scores in the main scales and 
symptoms subscales indicate higher levels of distress, whereas higher scores in the well-
being subscales indicate higher levels of well-being. 
The SQ has been validated in several languages, including Italian, and used in 
numerous studies among various age populations, and has shown to be a highly sensitive 
clinimetric index (Benasi et al., 2020). The questionnaire has also been found to have a good 
predictive and concurrent validity (Benasi et al., 2020). 
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For the purpose of the present study, the Italian version of the SQ (Fava et al., 1983) 
in its week form was used and the four main scales for anxiety, depression, hostility, and 
somatization were analyzed. 
• Psychosocial Index (PSI) (Piolanti et al., 2016; Sonino & Fava, 1998) 
The PSI is a 55-item self-report questionnaire that was originally developed as an instrument 
for the assessment of stress and other psychological dimensions in clinical practice, but can 
also be used in research settings, and covers the following clinical domains: 
▪ Stress: 17 items assessing both perceived and objective stress, life events, and 
chronic stress, with a total score ranging from 0 to 17, where higher scores indicate 
greater stress; 
▪ Well-being: 6 items assessing different aspects of well-being, including positive 
relations with others, environmental mastery, and autonomy, with a total score 
ranging from 0 to 6, where higher scores indicate greater well-being; 
▪ Psychological distress: 15 items assessing sleep disturbances, somatization, anxiety, 
depression, and irritability with a total score ranging from 0 to 45, where higher 
scores indicate greater distress. The 4 items about sleep disturbances can be scored 
separately, with a total score ranging from 0 to 12, where higher scores indicate 
greater sleep disturbances; 
▪ Abnormal illness behavior: 3 items for the assessment of hypochondriacal beliefs 
and bodily preoccupations with a total score ranging from 0 to 9, where higher 
scores indicate greater hypochondriacal beliefs and bodily preoccupations; 
▪ Quality of life: 1 item for the assessment of quality of life, with a score ranging from 
0 to 4, where higher scores indicate greater quality of life. The quality of life and 
well-being scores can be summed to obtain a global well-being score. 
Respondents are asked to answer each item using either a dichotomous (yes/no) or 
Likert scale. The questionnaire also includes 12 items for the collection of 
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sociodemographic and clinical data. The PSI has been used in various studies and has been 
shown to be a valid and sensitive tool to discriminate between various degrees of 
psychosocial impairment among different clinical populations (Piolanti et al., 2016). 
For the purpose of the present study, the Italian version of the PSI was used (Sonino & 
Fava, 1998), and the domains related to stress, psychological distress, and global well-being 
were analyzed. 
• Psychological Well-Being Scale (PWBs) (Ryff, 1989) 
The PWBs is a 42-item self-rating questionnaire for the assessment of psychological well-
being according to the multidimensional model developed by Jahoda (Jahoda, 1958). 
Specifically, the scale is composed of six scales corresponding to the six dimensions of 
psychological well-being: autonomy, environmental mastery, personal growth, purpose in 
life, self-acceptance, and positive relations with other. 
 Respondents are asked to rate the extent to which they agree with each item on a 6-
point Likert scale (from 1 = strongly disagree to 6 = strongly agree). Each scale can be rated 
separately, with scores ranging from 7 to 42 and higher scores indicating higher levels of 
psychological well-being in that specific dimension. The scale has shown good internal 
consistency (Cronbach's alpha coefficient = 0.81) (Sharma & Sharma, 2018) and test-retest 
reliability (Ryff, 1989).  
For the purpose of this study, the Italian version of the PWBs (Ruini et al., 2003) was 
used, and changes in all six dimensions of well-being were analyzed. 
• Body Weight and Body Mass Index (BMI) 
Body weight was measured in kilograms on a standard balance beam scale at each clinic or 
on a standard digital scale at participants’ home, as described above. BMI was calculated by 
dividing the body weight by the square of the body height and expressed in kg/m2. 
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3.4.4.4 Secondary Superiority Outcomes 
• GOSPEL Study Questionnaire (Giannuzzi et al., 2005, 2008) 
The GOSPEL questionnaire is a 32-item self-rating scale for the assessment of lifestyle in 
the past month. Specifically, the questionnaire can be used for the assessment of the 
following scales: 
▪ Mediterranean diet: 10 items evaluate the frequency of consumption of specific 
categories of foods and beverages (i.e., fruit, cooked and raw vegetables, fish, oil, 
butter, cheese, wine, and coffee). Each item is scored on a 4-point Likert scale and 
can be summed to obtain a Mediterranean diet score, ranging from 0 to 30, with 
higher scores indicating a better diet; 
▪ Dietary behavior: 3 items evaluate the frequency of behaviors during meals (i.e., eat 
regularly, slowly, and in a relaxed way). Each item is scored on a 4-point Likert 
scale and can be summed to obtain an eating habit score, ranging from 0 to 9, with 
higher scores indicating better eating habits. Mediterranean diet and behavioral 
aspects related to food consumption scores can also be summed to give a total diet 
score; 
▪ Physical activity: 5 items evaluate the frequency of specific types of physical activity 
(i.e., climbing stairs, doing manual work, walking, biking, free body exercise) on a 
4-point Likert scale, 2 items evaluate playing sports (yes/no) and time dedicated to it 
(  2 h or < 2 hours per week), and 1 item evaluates the overall self-perceived level of 
physical activity on a 4-point Likert scale. Scores on each item can be summed to 
obtain a total physical activity score, ranging from 0 to 20, with higher scores 
indicating higher levels of physical activity; 
▪ Stress: 7 items evaluate workload and frequency of a variety of self/stress 
management behaviors. Each item is scored on a 4-point Likert scale and can be 
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summed to obtain a self/stress management scale, with higher scores indicating 
inadequate self/stress management; 
▪ Family risk behaviors: 4 items that evaluate the presence of risk behaviors (i.e. 
smoking, unhealthy diet, sedentariness, and high stress) among family members on a 
dichotomous scale (present/absent), with higher scores indicating a higher number of 
risk behaviors; 
▪ Family support: 1 item that evaluates the perception of support from family members 
in making healthy lifestyle choices on a 4-point Likert scale, with higher scores 
indicating greater perceived support. 
The questionnaire has been used in the GOSPEL study for the assessment of patients with 
cardiovascular disease (Giannuzzi et al., 2005, 2008) and has been tailored to the dietary 
variation in the Italian adult population. 
 For the purpose of the present study, only the Mediterranean diet, dietary behavior, total 
diet, and physical activity scores were considered. Additional questions were asked to collect 
data on alcohol consumption (yes/no and number of alcoholic drinks per week), smoking habits 
(yes/no and number of cigarettes per day), sleep onset, and total sleep time with reference to the 
past month. 
• Physiological parameters 
The following physiological parameters were collected from medical charts for each participant 
at each assessment time: 
▪ HbA1c (%), a proxy measure of the 3-month average blood sugar level that is 
commonly used to diagnose type 2 diabetes and assess glycemic control in people 
with type 2 diabetes. Levels of HbA1c lower than 5.7% are considered normal 
(Centers for Disease Control and Prevention, 2019b); 
▪ HDL (mg/dL). Levels higher than or equal to 60 mg/dL are considered normal 
(Centers for Disease Control and Prevention, 2020a); 
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▪ LDL (mg/dL).  Levels lower than 100 mg/dL are considered normal (Centers for 
Disease Control and Prevention, 2020a); 
▪ Triglycerides (mg/dL). Levels lower than 150 mg/dL are considered normal (Centers 
for Disease Control and Prevention, 2020a); 
▪ Blood pressure (mm Hg). Levels of systolic blood pressure lower than 120 mm Hg 
and levels of diastolic blood pressure lower than 80 mm Hg are considered normal 
(Centers for Disease Control and Prevention, 2020b). 
 
3.4.5 Statistical analysis 
The sample size was estimated a priori using G*Power 3.1. Previous studies have shown a 
moderate effect size of psycho-behavioral interventions on weight loss and measures of depression 
and anxiety in adults with overweight or obesity (Rogers et al., 2017; Seo & Sa, 2008). To detect a 
medium effect size (d = 0.5) at the statistical power of 0.80, a minimum of 34 participants is 
required. Considering a risk of drop-out of about 50% (Moroshko et al., 2011), 68 participants were 
intended to be recruited. 
Main analyses on feasibility and acceptability were descriptive and focused on rates (i.e., 
eligibility, acceptance, and retention rates). Differences in retention rates between the combined 
WBT-lifestyle and the lifestyle alone group, and between study sites were analyzed by means of 
Pearson 2 test. The average number of sessions that had to be rescheduled was reported as mean 
and standard deviation (M±SD) and differences between intervention groups and study sites were 
assessed using independent samples Student t-test after controlling for Levene’s test for equality of 
variances. 
Content analysis was applied to participants’ answers to open-ended questions. Data were 
organized into segments, coded, and analyzed both qualitatively and quantitatively to determine 
which theme occurred most frequently. 
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Categorical variables were presented as frequencies, normally distributed continuous variables 
were presented as mean with standard deviation, and non-normally distributed continuous variables 
were presented as median with interquartile range. Baseline differences between intervention 
groups, study sites, and completers vs. non-completers were analyzed by means of Pearson 2 test 
for categorical variables, and by means of independent samples Student t-test after controlling for 
Levene’s test for equality of variances for normally distributed continuous variables and by means 
of the Mann-Whitney U test for non-normally distributed continuous variables. 
Intervention efficacy for all primary and secondary outcomes was assessed by linear mixed-
effects modeling (LMM) to estimate adjusted mean treatment difference and confidence intervals 
according to intention-to-treat (ITT) principles. Age, gender, high school education, site, and 
group*time interaction were included as fixed effects, and participant ID as a random effect, to 
analyze changes between and within groups over time. For studies with missing values, including 
both values missing at random and drop-out, a mixed model approach with no ad hoc imputation 
has been found to be more powerful than mixed models using ad hoc imputation methods (i.e., last 
observation carried forward (LOCF), best value replacement (BVR), and worst value replacement 
(WVR) (Chakraborty & Gu, 2009) and analysis of covariance (ANCOVA) with or without multiple 
imputation (MI) (Xi et al., 2018). Differences between groups in outcome measures at baseline 
were accounted for by using a constrained longitudinal data analysis (cLDA). This technique 
constrains baseline means to be equal between groups and has been found to be more efficient than 
ANCOVA and longitudinal data analysis (LDA) in providing accurate treatment effect estimates 
and robust inferential statistics (Coffman et al., 2016). Residual histograms of the efficacy 
outcomes were assessed visually and considered to be sufficiently normally distributed, and plots of 
the fitted values against the standardized residuals of the efficacy outcomes were assessed visually 
to confirm homoscedasticity. 
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Between group effect size estimates were reported as Cohen’s d calculated as adjusted mean 
difference between groups divided by pooled baseline standard deviation (Sheaves et al., 2018). A 
standardized effect size of 0.20 is considered small, 0.50 medium, and 0.80 large (Cohen, 1988). 
Statistical analyses were conducted in Stata/SE, version 16.1 (StataCorp 2019, College Station, 
TX, USA). Statistical significance was set at p ≤ 0.05, two-tailed, with 95% confidence intervals 
reported. 
 
3.5 Results  
3.5.1 Baseline characteristics of the sample 
3.5.1.1 Socio-demographic variables 
The socio-demographic profile of the study population is presented in Table 4. The mean 
age for the entire sample was 55.45 (SD = 6.60), ranging from 36 to 64, and with a higher 
prevalence of male participants (60.3%). The majority of participants were in a relationship 
(including those who were in a romantic relationship, in a domestic partnership, or married) 
(79.3%), were living with others (91.4%), had children (75.9%), and were employed (67.2%). 
Among those who were not in a relationship, 58.3 % were never married, 25% were divorced, and 
16.7% were a widow/widower. Among those who were unemployed, 52.6% were retired, 26.3% 
were a housemaker, 10.5% were looking for a job, and 10.5% said that they were home to take care 
of an elderly person. 
 No statistically significant difference in any of the socio-demographic variables considered 
was found when comparing participants in the combined WBT-lifestyle to the lifestyle alone group, 
between the two study sites, and between completers and those who did not complete the study 
(including both drop-out and participants who were eliminated by the investigator). Even if not 
statistically significant, a higher prevalence of female participants (50.0% vs. 28.6%) was observed 
in the combined WBT-lifestyle group. 
 58  
Table 4: Socio-demographic profile at baseline 
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3.5.1.2 Medical profile 
The medical profile of the study population is presented in Table 5. Participants had a 
median of 4.00 (IQR = 2.00-5.00) comorbidities at baseline, with 38% of participants having five or 
more comorbidities, 19% having four comorbidities, 17% having three comorbidities, 21% having 
two comorbidities, and only 5% having one comorbidity. A description of current medical 
comorbidities at baseline in the overall sample is provided in Figure 1. All participants had a 
diagnosis of type 2 diabetes, with a median of 6.00 (IQR = 3.00-12.00) years with diabetes. A 
family history of type 2 diabetes was also commonly reported among first and second-degree 
family members (74.1%). The most common comorbidities were cardiovascular (69%) and other 
metabolic diseases (55%), followed by eye (24%), musculoskeletal (19%), gastrointestinal (19%), 
nervous system (19%), genitourinary (16%), and respiratory (10%) diseases. Among cardiovascular 
disease (CVD), hypertension was the most common, being present in 62% of the total sample. 
Among metabolic diseases, hyperlipidemia and thyroid disease were present in 48% and 10% of the 
total sample, respectively. Common diabetes complications included peripheral neuropathy (22% of 
the total sample), retinopathy (16% of the total sample), and nephropathy (9% of the total sample). 
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Figure 1: Prevalence of medical comorbidities at baseline in the total sample (N=58) 
 
CVD = cardiovascular disease; GI = gastrointestinal; T2DM = type 2 diabetes 
 
 
Participants were monitored regularly by their physicians, with mean follow-up visits every 
6.20 (SD = 2.20) months. About half of participants monitored their glucose level at least once a 
month (52.6%) and most of them reported only partial compliance with medical recommendations 
(62.5%). Participants were asked to report which medical recommendations they were given to 
control their current medical condition. Pharmacological prescriptions (29%) were generally 
 61  
accompanied by indications on diet (27%) and physical activity (26%) (Figure 2). Diet 
recommendations could be general (e.g., “pay more attention to what you eat”, “reduce sugary and 
fatty foods consumption”, “eat more vegetables”) or include a specific dietary plan. Similarly, 
physical activity recommendations could be general (e.g., “move more and more regularly”) or 
more specific (e.g., “walk 30 minutes for at least 3 days a week”).  
 
Figure 2: Medical recommendations as reported by participants at baseline 
 
 
When asked about reasons for compliance, participants mentioned health improvement 
(88%) and weight loss (13%) (Figure 3). On the other hand, the most common reasons for not 
being compliant were lack of time (38%), generally due to work hours, lack of self-control (32%), 
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Physiological parameters show that at baseline participants were overall obese (median BMI 
31.95, IQR 27.80-37.60 kg/m2) and had elevated blood sugar (HbA1c 8.12±1.46%), poor lipid 
profile (HDL 47.64±13.23 mg/dL and triglycerides 192.24±131.85 mg/dL), and high blood pressure 
(SBP 132.08±15.24 mm Hg). All study participants were taking diabetes medications, but only a 
minority (22.4%) had been prescribed insulin.  
There was no statistically significant difference in any of the medical variables considered 
between the combined WBT-lifestyle and lifestyle alone groups and between participants who did 
or did not complete the study. A significantly greater proportion of participants from the hospital in 
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Cremona reported regularly monitoring their glucose levels and had significantly lower HbA1c 
(7.38±1.23% vs. 8.43±1.45%). 
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Table 5: Medical profile at baseline 
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Table 5: (continued) 
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BMI = Body Mass Index; DBP = diastolic blood pressure; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; kg = kilograms; LDL = low-density 
lipoprotein; m = months; n = number; SBP = systolic blood pressure; TG = triglycerides; T2DM = type 2 diabetes; y = years 
*Normal values: BMI between 18.5 and 24.9 kg/m2; HbA1c between 4.0 and 5.6%; HDL ≥ 60 mg/dL; LDL < 100 mg/dL; TG < 150 mg/dL; SBP between 90 
and 119 mm Hg; DBP between 60 and 79 mm Hg 
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3.5.1.3 Weight history 
Participants’ weight history is reported in Table 6. Overall, participants had been 
overweight or obese for a median of 20.00 (IQR = 11.00-36.00) years. Most participants tried to 
lose weight at least once in their life (81%), with a median of 2.00 (IQR = 1.00-3.00) attempts. In 
the majority of cases, weight loss attempts revolved around diet (58%) (i.e., dietary plan overseen 
by a dietician, dietary products, books for diabetes, meal replacement, self-administered low 
carbohydrate, hypocaloric, macrobiotic, and Dukan diet) and physical activity (32%) (i.e., walking, 
going to the gym, swimming, stationary bike, and rugby). Only a small minority of participants 
relied on weight loss centers, psychological interventions, medications, or surgery to lose weight 
(Figure 4).  
 
Figure 4: Description of past weight loss attempts as reported by participants at baseline 
 
 
When asked which factors influenced their ability to lose weight and maintain results in the 
past, participants commonly reported engaging in a healthy diet (41%) as a factor favoring weight 
loss (Figure 5), while having an unhealthy diet (18%), lack of perseverance (15%), and stress 
(14%) as factors interfering with weight loss (Figure 5).  
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At time of recruitment, about half of the participants were actively trying to lose weight 
(53.4%). Common methods to lose weight included walking (20%), making healthy food choices 
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Figure 6: Description of current weight loss attempts as reported by participants at baseline 
 
 
Improving their health was the most common reason for trying to lose weight (76%). Other 
reasons were improving self-image (15%) and daily performance (9%) (Figure 7). 
 




 69  
Only a minority of participants was being followed by the dietician at the diabetes clinic 
(25.9%). Most participants were regularly monitoring their weight at least once a month (67.9%) 
and were in charge of buying and preparing food for their family (64.3% and 51.8%, respectively) 
(Table 6).  
There was no statistically significant difference in any of the weight-related variables 
between treatment groups and between participants who did or did not complete the study. A 
significantly greater proportion of participants from the hospital in Cremona was followed by the 
diabetes clinic’s dietician (50% vs. 16.7 %). 
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Table 6: Weight history at baseline 
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Table 6: (continued) 
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N = number; WL = weight loss; y = years 
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3.5.1.4 Psychological profile 
The psychological profile of the study population is presented in Table 7. Only a minority 
of participants had been diagnosed with a psychiatric condition in the past (12.1%), including 
depression, post-partum depression, panic attacks, and anxiety. A relatively higher percentage of 
participants reported having received a psychological or psychiatric intervention in the past 
(24.1%), since this includes both interventions to address specific psychiatric conditions (i.e., 
pharmacotherapy, psychotherapy, and hospitalization) and counseling interventions to manage 
stress, lose weight, adapt to the diagnosis of diabetes, and quit smoking.  
Participants were assessed for the presence of psychiatric diagnoses according to the DSM-5 
criteria (American Psychiatric Association, 2013) and the DSM-IV-TR (American Psychiatric 
Association, 2000) criteria for minor depression. At least one diagnosis that did not meet the study 
exclusion criteria (i.e., untreated, severe, or recently diagnosed) was present in 19% of the total 
sample (Table 7). Overall, the most common diagnosis was minor depression (9%) (Figure 8). 
 
Figure 8: Prevalence of DSM-5 diagnoses and minor depression at baseline 
 
 




* p ≤ .05 
GAD = generalized anxiety disorder; OCD = obsessive compulsive disorder 
 
At least one DCPR syndrome was identified in 83% of the total sample (Table 7). The most 
common syndromes were alexithymia (47%), illness denial (29%), allostatic overload (28%), 
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Figure 9: Prevalence of DCPR syndromes at baseline 
 
 
 * p ≤ .05 
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No significant differences were observed between the combined WBT-lifestyle and lifestyle 
alone groups and between participants from different study sites in any of the psychological profile 
variables considered, or in the prevalence of DSM diagnoses and DCPR syndromes. However, a 
significantly higher prevalence of minor depression (27% vs. 2%, p = .004) and irritable mood 
(33% vs. 5%, p = .003) was observed at baseline in participants who did not complete the study. 
Baseline levels of psychological well-being and distress are reported in Table 8. Scores of 
psychological well-being and distress were similar among the combined WBT-lifestyle and lifestyle 
alone groups. Significantly higher levels of psychological distress were observed in participants 
from the hospital in Cremona (6.98±5.58 vs. 10.31±5.30, p = .045), and lower levels of autonomy 
(31.65±6.11 vs. 29.00±3.14, p = .037) were observed among non-completers. 
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Table 7: Psychological profile at baseline 
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Table 8: Baseline levels of psychological well-being and distress 
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*Score range, bolded numbers represent the worst scores 
PSI = Psychosocial Index; PWBs = Psychological Well-Being scales; SQ = Symptom Questionnaire 
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3.5.1.5 Lifestyle  
Baseline lifestyle variables in the study population are presented in Table 9. Measures of 
diet and physical activity were similar among the combined WBT-lifestyle and lifestyle alone 
groups, study sites, and between completers and non-completers. 
Overall, study participants reported a mean of 6.6 hours (SD = 1.1) of sleep per night, 
ranging from 4 to 9 hours, and a median sleep onset time of 10.0 minutes (IQR = 5.00-30.00), 
ranging from 0 to 120 minutes. While there were no significant differences between participants 
based on the allocation to the combined WBT-lifestyle or lifestyle alone group and study 
completion, participants from the hospital in Cesena slept significantly longer than those in the 
hospital in Cremona (6.8±1.2 vs. 6.0±0.8, p = .017). 
No participant reported using any recreational drug. About half of the sample reported 
consuming alcohol (44.8%) and only a minority of participants were smokers (20.7%). Participants 
consumed a median of 0 (IQR = 0.00-1.50) glasses of alcoholic drinks per week, ranging from 0 to 
24, and smoked a median of 0 (IQR = 0.00-0.00) cigarettes per day, ranging from 0 to 40. A 
significantly greater percentage of participants in the lifestyle alone group reported alcohol 
consumption (60.7% vs. 30.0%, p = .019), and significant differences were observed between the 
combined WBT-lifestyle and lifestyle alone groups in the median number of glasses of alcoholic 
drinks consumed per week (1.00, IQR 0.00-2.50 vs. 0.00, IQR 0.00-0.00, p = .029). 
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Table 9: Baseline lifestyle variables  
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Table 9: (continued) 
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Alcohol              
Yes 26 (44.8) 9  
(30.0) 
17 (60.7) 5.52 
(1) 











No 32 (55.2) 21  
(70.0) 
11 (39.3)   22 (52.4) 10  
(62.5) 
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No 46 (79.3) 26  
(86.7) 
20 (71.4)   34 (81.0) 12  
(75.0) 





Recreational drugs              
Yes 0  - -  - - -  - - -  - 
No 100  - -  - - -  - - -  - 
h = hours; m = minutes 
*Score range, bolded numbers represent the worst scores 
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3.5.2 Lifestyle engagement 
Figure 10 shows the prevalence of each eating and physical activity strategy in the total 
sample. The most commonly chosen eating strategies were “half of your main meal should be 
vegetables” (22%), “use a smaller plate for your main meal” (21%), “take time for your meals 
(don’t skip a meal)” (18%), and “eat a fruit or vegetable before salty or sugary snacks” (17%). 
 
Figure 10: Prevalence of eating and physical activity strategies in the total sample (N=58) 
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3.5.3 Feasibility and acceptability 
A total of 58 participants were enrolled in the study (Figure 11). Most of the patients 
attending the two clinics during the time of enrollment were not eligible because they were older 
than 65 years (74.1%). Among those who were eligible, 24% consented to participate. The main 
reasons for refusal were lack of time due to work (40.6%) and family obligations (19.8%). Of those 
who were enrolled in the study, 74.1% completed the T1 and 70.7% completed the T2 assessment. 
At T1 the group of non-completers included both participants who discontinued the intervention 
(19%) and participants who were excluded by the investigator due to worsening of their medical 
condition (6.9%). At T2 an additional two participants were lost to follow-up.  
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Assessed for eligibility (N=3390)  Enrollment 
Excluded due to ineligibility (N=3145)  
   Age > 65 years (n=2329) 
   Type 1 diabetes (n=227) 
   Language (n=184) 
   Psychiatric disorder (n=108)   
   Medical condition (n=99) 
   BMI < 25 kg/m2 (n=66) 
   No T2DM (n=56) 
   Pregnancy (n=43) 
   Bariatric surgery (n=7) 
   Cognitive impairment (n=7) 
   Hospitalized (n=6) 
   Psychological intervention (n=5) 
   Weight loss drugs (n=4) 
   Substance abuse (n=3) 





   Work (n=76) 
   Family problems (n=37) 
   Unspecified (n=30) 
   Not interested (n=20) 
   Living abroad or far away (n=13) 
   Lack of transportation (n=6) 
   Intervention too challenging (n=2) 
   Skeptical about psychologists (n=2) 
   No guarantees for intervention efficacy (n=1) 
Combined WBT-lifestyle group (n= 30) Lifestyle alone group (n= 28) 
Allocation 
 
ITT analysis (n=30)  
 
 




Completed intervention (n=20) 
Discontinued (n=7) 
• Work (n=4) 
• Illness in the family (n=1) 
• Lost (n=1) 
• No more interested (n=1) 
Excluded (n=3) 
• Medical condition (n=3) 
T2: 
Completed follow-up (n=18) 
Lost (n=2) 
T1: 
Completed intervention (n=23) 
Discontinued (n=4) 
• Work (n=1) 
• Lack of motivation (n=1) 
• Lost (n=2) 
Excluded (n=1) 
• Medical condition (n=1) 
T2: 
Completed follow-up (n=23) 
Lost (n=0) 
Follow-up 
 84  
There were no significant differences in rates of retention (i.e., completion, drop-out, and 
exclusion) at T1 between the combined WBT-lifestyle and lifestyle alone groups, but a significantly 
higher study completion rate was observed among participants in the hospital in Cremona (93.8% 
vs. 66.7%, p = .035) (Figure 12). 
 
Figure 12: Rates of retention at T1 in the total sample, the combined WBT-lifestyle and lifestyle 
alone groups, and study sites 
 
* p ≤ .05 
 
Missed sessions were rescheduled until participants completed 16 sessions in the combined 
WBT-lifestyle group and 12 sessions in the lifestyle alone group. On average, participants asked to 
reschedule 1 (SD =1.59) session, ranging from 0 to 8 sessions, before completing the study. 
When asked which component of the study they found to be the most useful, participants 
often mentioned receiving psychological support (30%), being given information on how to 
improve their lifestyle (26%), and having regular meetings (20%) (Figure 13). Most participants 
said there was no component of the study that they found to be the least useful (77%), while a 
smaller group of participants stated the least useful component was the questionnaire for being long 
and redundant (10%), keeping a well-being diary (6%), having regular meetings (3%), and talking 
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over the phone instead of meeting in person (3%) (Figure 13). Most participants felt that the study 
helped them to improve their diet (39%) and physical activity (36%) (Figure 13). Finally, 
participants’ suggestions for improvement included having group sessions to share the experience 
with other participants, additional follow-up sessions after the end of the intervention, meetings 
with a dietician, more frequent meetings, replacing some of the phone calls with in person 
meetings, setting more intense goals, and using a shorter questionnaire (Figure 13). 
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3.5.4 Primary Superiority Outcomes 
3.5.4.1 Psychological distress 
At T1, the combined WBT-lifestyle group had a significantly greater treatment benefit in the 
medium effect size range in reducing levels of SQ depression and hostility, compared with the 
lifestyle alone group. Between-group differences were no longer significant at T2 for both measures 
of SQ depression and hostility (Table 10). Findings for SQ depression and hostility scores are 
graphically presented in Figures 14 and 15. 
Levels of SQ depression significantly decreased from T0 to T1 in the combined WBT-
lifestyle group, and from T0 to T2 in both the combined WBT-lifestyle and lifestyle alone groups. 
Levels of SQ hostility significantly decreased over time in the combined WBT-lifestyle group, 
while no significant change was observed in the lifestyle alone group at any time point (Table 11). 
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Figure 15: Marginal predicted mean of SQ hostility (N=58) 
 
 
At both T1 and T2, there were no significant differences between the combined WBT-
lifestyle and lifestyle alone groups in measures of SQ anxiety and somatization, or PSI stress and 
psychological distress (Table 10). Findings for SQ anxiety and somatization, and PSI stress and 
psychological distress scores are graphically presented in Figures 16-19.  
Within groups, levels of SQ somatization and PSI stress significantly decreased over time in 
the combined WBT-lifestyle group, but not in the lifestyle alone group, where no significant change 
was observed at any time point. Levels of SQ anxiety and PSI psychological distress significantly 
improved from T0 to T1 in the combined WBT-lifestyle group. At T2 significant improvements 
were observed in both the combined WBT-lifestyle and lifestyle alone groups for levels of PSI 
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Figure 16: Marginal predicted mean of anxiety (N=58) 
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Figure 18: Marginal predicted mean of stress (N=58) 
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3.5.4.2 Psychological well-being 
At T1, there was a significantly greater improvement in the medium effect size range in 
levels of PWBs personal growth in the combined WBT-lifestyle group. Differences between the 
combined WBT-lifestyle and lifestyle alone groups were no longer significant at T2 (Table 10). 
Findings for personal growth scores are graphically presented in Figure 20. 
 Levels of personal growth significantly increased in the combined WBT-lifestyle group 
from T0 to T1, but no significant changes were observed from T0 to T2 in the combined WBT-
lifestyle group, or at any time point in the lifestyle alone group (Table 11).  
 
Figure 20: Marginal predicted mean of personal growth (N=58) 
 
 
At both T1 and T2, there were no significant differences between the combined WBT-
lifestyle and lifestyle alone groups in measures of PWBs autonomy, environmental mastery, 
purpose in life, positive relations, self-acceptance, and PSI global well-being (Table 10). Findings 
for autonomy, environmental mastery, purpose in life, positive relations, self-acceptance, and global 
well-being scores are graphically presented in Figures 21-26.  
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In the combined WBT-lifestyle group, there was a significant increase in levels of global 
well-being, autonomy, environmental mastery, and self-acceptance from T0 to T1. These changes 
were still significant at T2 only for the measures of autonomy and environmental mastery. In the 
lifestyle alone group, there was a significant increase in levels of autonomy from T0 to T1. 
Improvements in autonomy were maintained at T2 and an additional significant increase was 
observed in measures of environmental mastery and global well-being (Table 11). 
 
Figure 21: Marginal predicted mean of autonomy (N=58) 
 
Figure 22: Marginal predicted mean of environmental mastery (N=58) 
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Figure 23: Marginal predicted mean of purpose in life (N=58) 
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Figure 25: Marginal predicted mean of self-acceptance (N=58) 
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3.5.4.3 Weight 
At both T1 and T2, there were no significant differences in weight change between the 
combined WBT-lifestyle and lifestyle alone groups (Table 10). Findings for weight change in kg 
are graphically presented in Figure 27. 
A statistically significant within-group decrease in weight was observed in both the 
combined WBT-lifestyle and lifestyle alone group over time (Table 11). 
 
Figure 27: Marginal predicted mean of weight (N=58) 
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Adjusted mean difference 




effect size (d) 
Anxiety (SQ)      
T0 5.09 [4.12,6.06] 5.09 [4.12,6.06]    
T1 3.14 [1.61,4.66] 4.55 [3.13,5.97] -1.41 [-3.38,0.56] .162 -0.34 
T2 3.76 [2.16,5.35] 3.19 [1.77,4.62] 0.56 [-1.47,2.60] .588 0.13 
Depression (SQ)      
T0 4.56 [3.70,5.43] 4.56 [3.70,5.43]    
T1 2.27 [1.02,3.51] 4.35 [3.14,5.57] -2.09 [-3.66,-0.51] .009 -0.55 
T2 2.51 [1.20,3.83] 3.19 [2.01,4.37] -0.68 [-2.28,0.93] .409 -0.18 
Somatization (SQ)      
T0 7.82 [6.46,9.19] 7.82 [6.46,9.19]    
T1 5.74 [3.74,7.75] 7.09 [5.12,9.05] -1.35 [-3.91,1.21] .302 -0.24 
T2 5.65 [3.56,7.73] 6.05 [4.16,7.95] -0.41 [-2.99,2.17] .757 -0.07 
Hostility (SQ)      
T0 4.36 [3.32,5.39] 4.36 [3.32,5.39]    
T1 2.56 [1.03,4.09] 5.18 [3.68,6.67] -2.61 [-4.56,-0.67] .008 -0.59 
T2 1.75 [0.16,3.35] 3.123 [1.67,4.58] -1.37 [-3.34,0.60] .173 -0.31 
Stress (PSI)      
T0 2.82 [2.25,3.39] 2.82 [2.25,3.39]    
T1 1.85 [1.06,2.64] 2.49 [1.74,3.24] -0.64 [-1.54,0.27] .169 -0.26 
T2 1.71 [0.89,2.53] 2.20 [1.45,2.95] -0.49 [-1.43,0.44] .300 -0.21 
Psychological distress (PSI)      
T0 8.29 [6.99,9.60] 8.29 [6.99,9.60]    
T1 5.27 [3.423,7.11] 7.29 [5.52-9.07] -2.02 [-4.27,0.23] .078 -0.36 
T2 6.50 [4.59,8.41] 5.62 (3.76-7.49] 0.88 [-1.50,3.25] .469 -0.15 
Global well-being (PSI)      
T0 7.32 [6.93,7.72] 7.32 [6.93,7.72]    
T1 7.99 [7.45,8.53] 7.52 [7.01,8.03] 0.46 [-0.14,1.07] .135 0.27 
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Table 10: (continued) 
 Combined WBT-lifestyle (n=30)* 
 
Lifestyle alone (n=28)* Adjusted mean 
difference between 
groups (95% CI)** 
p Between-group 
standardized 
effect size (d) 
Autonomy (PWBs)      
T0 30.95 [29.65,32.26] 30.95 [29.65,32.26]    
T1 33.95 [31.78,36.12] 33.75 [31.73,35.77] 0.20 [-2.71,3.12] .893 0.04 
T2 34.29 [32.01,36.57] 32.97 [30.95,34.99] 1.32 [-1.68,4.33] .387 0.24 
Environmental mastery (PWBs)      
T0 28.81 [27.40,30.23] 28.81 [27.40,30.23]    
T1 31.26 [29.24,33.29] 30.45 [28.48,32.43] 0.81 [-1.69,3.31] .525 0.13 
T2 31.03 [28.93,33.13] 31.43 [29.51,33.35] -0.40 [-2.91,2.12] .757 -0.06 
Personal growth (PWBs)      
T0 30.08 [28.67,31.49] 30.08 [28.67,31.49]    
T1 32.58 [30.38,34.77] 29.14 [27.04,31.24] 3.43 [0.55,6.32] .020 0.55 
T2 30.67 [28.38,32.96] 30.95 [28.89,33.01] -0.28 [-3.20,2.65] .852 -0.05 
Positive relations (PWBs)      
T0 31.69 [30.33,33.05] 31.69 [30.33,33.05]    
T1 32.79 [30.62,34.96] 32.47 [30.44,34.50] 0.32 [-2.53,3.18] .825 0.1 
T2 33.31 [31.04,35.58] 32.95 [30.92,34.97] 0.37 [-2.57,3.3] .807 0.1 
Purpose in life (PWBs)      
T0 29.27 [28.03,30.52] 29.27 [28.03,30.52]    
T1 30.10 [28.17,32.03] 28.78 [26.96,30.59] 1.33 [-1.22,3.87] .306 0.23 
T2 30.76 [28.70,32.82] 30.60 [28.79,32.42] 0.16 [-2.49,2.80] .907 0.03 
Self-acceptance (PWBs)      
T0 29.62 [27.99,31.26]  29.62 [27.99,31.26]    
T1 32.63 [30.29,34.96] 30.10 [27.88,32.31] 2.53 [-0.33,5.39] .082 0.36 
T2 31.81 [29.38,34.23] 30.44 [28.23,32.66] 1.36 [-1.57,4.29] .363 0.20 
Weight (kg)      
T0 95.03 [90.20,99.86] 95.03 [90.20,99.86]    
T1 92.52 [87.52,97.53] 93.28 [88.31,98.25] -0.76 [-2.99,1.48] .507 -0.04 
T2 92.84 [87.82,97.86] 93.40 [88.43,98.38] -0.56 [-2.82,1.70] .625 -0.03 
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Table 11:  Within-group change over time in primary efficacy outcome measures (N=58) 
 Time effect combined WBT-
lifestyle group T0/T1 
 
Time effect combined WBT-
lifestyle group T0/T2 
 
Time effect lifestyle alone 
group T0/T1 
 
Time effect lifestyle alone 
group T0/T2 
 
Anxiety (SQ) -1.95 [-3.49,-0.42]* -1.33 [-2.95,0.29] -0.54 [-1.96,0.87] -1.90 [-3.32,-0.48]* 
Depression (SQ) -2.30 [-3.47,-1.13]* -2.05 [-3.30,-0.80]* -0.21 [-1.36,0.94] -1.37 [-2.48,-0.26]* 
Somatization (SQ) -2.08 [-4.00,-0.16]* -2.18 [-4.18,-0.17]* -0.73 [-2.58,1.12] -1.77 [-3.55,0.01] 
Hostility (SQ) -1.79 [-3.24,-0.35]* -2.60 [-4.11,-1.10]* 0.82 [-0.603,-2.242] -1.234 [-2.622,-0.15] 
Stress (PSI) -0.97 [-1.65,-0.29]* -1.11 [-1.83,-0.4]* -0.33 [-0.97,0.30] -0.62 [-1.25,0.01] 
Psychological distress (PSI) -3.02 [-4.70,-1.34]* -1.79 [-3.55,-0.04]* -1.00 [-2.60,0.60] -2.67 [-4.37,-0.97]* 
Global well-being (PSI) 0.66 [0.21,1.12]* 0.39 [-0.06,0.85] 0.20 [-0.23,0.62] 0.58 [0.17,0.97]* 
Autonomy (PWBs) 2.99 [0.68,5.32]* 3.34 [0.92,5.76]* 2.80 [0.62,4.97]* 2.01 [-0.16,4.19]* 
Environmental mastery (PWBs) 2.45 [0.60,4.31]* 2.22 [0.28,4.15]* 1.64 [-0.16,3.44] 2.61 [0.88,4.35]* 
Personal growth (PWBs) 2.49 [0.30,4.69]* 0.59 [-1.70,2.88] -0.94 [-3.04,1.16] 0.87 [-1.19,2.93] 
Positive relations (PWBs) 1.10 [-1.12,3.32] 1.62 [-0.70,3.94] 0.78 [-1.31,2.86] 1.26 [-0.83,3.34] 
Purpose in life (PWBs) 0.83 [-1.13,2.78] 1.49 [-0.60,3.57] -0.50 [-2.37,1.38] 1.33 [-0.55,3.20] 
Self-acceptance (PWBs) 3.00 [0.84,5.17]* 2.18 [-0.08,4.44] 0.47 [-1.55,2.49] 0.82 [-1.2,2.84] 
Weight (kg) -2.51 [-4.15,-0.87]* -2.19 [-3.86,-0.52]* -1.75 [-3.28,-0.22]* -1.63 [-3.16,-0.10]* 
Note: Data are reported as marginal predicted means (95% CI). Analyses were adjusted for age, gender, site, and education. 
* p ≤ .05 
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3.5.5 Secondary Superiority Outcomes 
3.5.5.1 Lifestyle 
At T1 there were no significant differences between the combined WBT-lifestyle and 
lifestyle alone groups in levels of physical activity. However, at T2 there was a significantly greater 
increase in levels of physical activity in the combined WBT-lifestyle group (Table 12). Findings for 
physical activity change are graphically presented in Figure 28. 
A statistically significant increase in physical activity was observed in the combined WBT-
lifestyle group from T0 to T1 and T2, while no significant change occurred in the lifestyle alone 
group at any time point (Table 13). 
 
Figure 28: Marginal predicted mean of physical activity (N=58) 
 
 
No significant between-group differences were observed in any of the diet measures 
considered at both T1 and T2 (Table 12). Findings for Mediterranean diet, dietary behavior, and 
total diet change are graphically presented in Figures 29-31.  
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There were no significant within-group changes in measures of diet in the combined WBT-
lifestyle group. In the lifestyle alone group, diet total scores significantly improved from T0 to T1, 
while dietary behavior scores significantly improved from T0 to T2 (Table 13). 
 
Figure 29: Marginal predicted mean of Mediterranean diet (N=58) 
 
 




 101  
Figure 31: Marginal predicted mean of total diet (N=58) 
 
 
3.5.5.2 Physiological parameters 
At both T1 and T2, there were no significant differences between the combined WBT-
lifestyle and lifestyle alone groups in any of the physiological parameters considered. However, 
changes in blood pressure favored the combined WBT-lifestyle group with a medium to large effect 
size at T2 for the systolic blood pressure measure and at both T1 and T2 for the diastolic blood 
pressure measure (Table 12). Findings for HbA1c, HDL, LDL, triglycerides, and systolic and 
diastolic blood pressure change are graphically presented in Figures 32-37. 
 No significant within-group changes were observed in measures of LDL and triglycerides in 
any of the combined WBT-lifestyle and lifestyle alone groups. Levels of HbA1c significantly 
decreased from T0 to T1 in both the combined WBT-lifestyle and lifestyle alone groups, but no 
significant changes were observed from T0 to T2. In the combined WBT-lifestyle group, levels of 
HDL significantly increased from T0 to T1, while systolic and diastolic blood pressure significantly 
improved from T0 to T2 (Table 13). 
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Figure 32: Marginal predicted mean of HbA1c (N=58) 
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Figure 34: Marginal predicted mean of LDL (N=58) 
 
 








 104  
Figure 36: Marginal predicted mean of systolic blood pressure (N=58) 
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Table 12:  Between-group differences in secondary efficacy outcome measures (N=58) 
 Combined WBT-lifestyle 
(n=30)* 
 
Lifestyle alone (n=28)* Adjusted mean 
difference between 
groups (95% CI)** 
p Between-group standardized 
effect size (d) 
Mediterranean diet (GOSPEL)      
T0 17.11 [16.42,17.80] 17.11 [16.42,17.80]    
T1 17.21 [16,17,18.25] 17.75 [16.78,18.71] -0.54 [-1.86,0.79] .425 -0.20 
T2 17.09 [16.03,18.16] 17.23 [16.26,18.19] -0.13 [-1.47,1.21] .847 -0.05 
Dietary behaviors (GOSPEL)      
T0 5.52 [5.11,5.93] 5.52 [5.111,5.93]    
T1 5.82 [5.21,6.44] 5.85 [5.26,6.44] -0.03 [-0.82,0.77] .951 -0.01 
T2 5.70 [5.06,6.34] 6.15 [5.564,6.74] -0.45 [-1.27,0.36] .273 -0.24 
Total diet (GOSPEL)      
T0 22.47 [21.61,23.32] 22.47 [21.61,23.32]    
T1 22.92 [21.64,24.20] 23.69 [22.50,24.88] -0.77 [-2.38,0.85] .353 -0.22 
T2 22.79 [21.48,24.09] 23.47 [22.28,24.66] -0.68 [-2.32,0.95] .413 -0.19 
Physical activity (GOSPEL)      
T0 5.07 [4.33,5.81] 5.07 [4.33,5.81]    
T1 6.47 [5.24,7.70] 6.23 [5.06,7.40] 0.24 [-1.41,1.90] .775 0.08 
T2 7.23 [5.97,8.49] 5.32 [4.20,6.43] 1.92 [0.28,3.56] .022 0.65 
HbA1c (%)      
T0 8.19 [7.85,8.52] 8.19 [7.85,8.52]    
T1 7.67 [7.12,8.21] 7.55 [6.99,8.12] 0.12 [-0.61,0.84] .757 0.08 
T2 7.81 [7.17,8.46] 8.20 [7.59,8.82] -0.39 [-1.23,0.45] .364 -0.27 
HDL (mg/dL)      
T0 45.89 [42.44,49.33]  45.89 [42.44,49.33]    
T1 50.26 [45.16,55.37] 45.07 [40.33,49.81] 5.19 [-0.61,10.99] .080 0.37 
T2 47.54 [42.31,52.76] 43.99 [39.42,48.56] 3.55 [-2.13,9.23] .221 0.26 
LDL (mg/dL)      
T0 98.91 [88.51,109.31] 98.91 [88.51,109.31]    
T1 104.37 [81.96,126.78] 100.65 [83.69,117.61] 3.72 [-24.32,31.75] .795 0.12 
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Table 12: (continued) 
 Combined WBT-lifestyle (n=30)* 
 
Lifestyle alone (n=28)* Adjusted mean 
difference between 
groups (95% CI)** 
p Between-group 
standardized 
effect size (d) 
Triglycerides (mg/dL)      
T0 186.89 [151.02,222.75] 186.89 [151.02,222.75]    
T1 200.70 [148.21,253.18] 192.72 [144.87,240.57] 7.98 [-50.27,66.22] .788 0.06 
T2 168.70 [112.39,225.01] 163.93 [114.62,213.23] 4.77 [-57.87,67.41] .881 0.04 
Systolic BP (mm Hg)      
T0 132.27 [128.55,136.00] 132.27 [128.55,136.00]    
T1 126.38 [119.26,133.51] 130.59 [121.42,139.76] -4.21 [-15.60,7.19] .469 -0.28 
T2 122.70 [114.54,130.85] 131.21 [123.39,139.02] -8.51 [-19.58,2.56] .132 -0.56 
Diastolic PB (mm Hg)      
T0 77.71 [75.93,79.49] 77.71 [75.93,79.49]    
T1 75.50 [72.17,78.82] 80.35 [76.00,84.69] -4.85 [-10.18,0.47] .074 -0.67 
T2 72.99 [69.17,76.80] 77.51 [73.86,81.15] -4.52 [-9.65,0.61] .084 -0.63 
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Table 13:  Within-group change over time in secondary efficacy outcome measures (N=58) 
 Time effect combined WBT-
lifestyle group T0/T1 
 
Time effect combined WBT-
lifestyle group T0/T2 
 
Time effect lifestyle alone 
group T0/T1 
 
Time effect lifestyle 
alone group T0/T2 
 
Mediterranean diet (GOSPEL) 0.10 [-0.92,1.12] -1.33 [-2.95,0.29] 0.64 [-0.32,1.60] 0.12 [0.84,1.08] 
Dietary behaviors (GOSPEL) 0.31 [-0.30,0.91] 0.18 [-0.45,0.81] 0.33 [-0.24,0.90] 0.63 [0.06,1.20]* 
Total diet (GOSPEL) 0.46 [-0.78,1.69] 0.32 [-0.94,1.59] 1.22 [0.05,2.39]* 1.01 [-0.17,2.18] 
Physical activity (GOSPEL) 1.40 [0.12,2.69]* 2.17 [0.85,3.48]* 1.16 [-0.08,2.40] 0.25 [-0.93,1.43] 
HbA1c (%) -0.52 [-1.03,-0.01]* -0.37 [-0.99,0.24] -0.63 [-1.17,-0.10]* 0.015 [-0.57,0.60] 
HDL (mg/dL) 4.38 [0.05,8.71]* 1.65 [-2.76,6.06] -0.81 [-4.84,3.22] -1.90 [-5.65,1.85] 
LDL (mg/dL) 5.46 [-14.99,25.92] 6.89 [-13.85,27.63] 1.74 [-15.68,19.17] 1.56 [-13.43,16.55] 
Triglycerides (mg/dL) 13.81 [-30.30,57.93] -18.19 [-67.42,31.05] 5.84 [-33.68,45.35] -22.96 [-63.62,17.71] 
Systolic BP (mm Hg) -5.89 [-13.12,1.34] -9.58 [-17.83,-1.32]* -1.68 [-10.90,7.54] -1.07 [-9.01,6.87] 
Diastolic PB (mm Hg) -2.22 [-5.55,1.12] -4.73 [-8.55,-0.90]* 2.64 [-1.70,6.97] -0.20 [-3.87,3.47] 
Note: Data are reported as marginal predicted means (95% CI). Analyses were adjusted for age, gender, site, and education. 
* p ≤ .05 
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3.6 Discussion  
This study evaluated the feasibility, acceptability, and superiority of a combined well-being 
and lifestyle intervention for weight loss and distress reduction in a sample of 58 adult patients with 
type 2 diabetes compared to a lifestyle intervention alone. 
With respect to feasibility and acceptability, our intervention showed a retention rate of 
about 70% after 10 months from the beginning of the intervention. High rates of attrition are one 
the major challenges in the treatment of obesity. Although attrition rates are highly variable across 
studies, ranging from 10% to 80% (Moroshko et al., 2011), a mean attrition rate of more than 40% 
within the first 12 months has been reported in previous weight loss trials. For example, in two 
studies from the Italian population, 51.7% (Dalle Grave et al., 2005) and 77.3% (Inelmen et al., 
2005) of study participants discontinued the intervention after 12 months. Numerous factors have 
been associated with attrition in weight loss programs, but findings are often mixed and 
inconsistent, with only a small number of studies reporting a specific factor. In a recent systematic 
review (Leung et al., 2017), older age, higher education, healthier eating and physical activity, 
higher stage of change at baseline, and higher initial weight loss were commonly associated with 
better adherence to lifestyle modification programs for weight loss, while presence of depression, 
stress, body image concerns, and having a full-time job were common predictors of poor adherence. 
In line with these findings, an unhealthy diet, lack of physical activity, stress, work constraints, and 
lack of initial results were among the factors reported by our study participants as interfering with 
their past attempts to lose weight. Moreover, in the present study, non-completers had significantly 
lower baseline levels of autonomy compared with study completers and showed significantly higher 
rates of minor depression and irritable mood. The role of these variables as predictors of attrition in 
weight loss programs appear to be relatively unexplored in the literature. For example, levels of 
anger-hostility have been found to be independently associated with attrition among adult patients 
undergoing a behavioral weight loss treatment (Colombo et al., 2014). However, only one study 
(Altamura et al., 2018) specifically considered the impact of DCPR syndromes on attrition and 
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found that even if non-completers had significantly higher rates of alexithymia, irritable mood, and 
type A behavior, only alexithymia was a significant predictor of attrition. Positing a mechanism 
behind the good rates of retention observed in our study compared to similar studies in this field is 
difficult due to the heterogeneity of interventions and study designs. Nevertheless, our retention 
rates are promising and appear to be better than those of most weight loss studies. 
Despite these promising results, only 24% of eligible patients accepted to participate in the 
study. A common barrier to both study enrollment and retention cited by participants or potential 
participants was a lack of time due to family and work constraints. A potential solution to this is 
transitioning to more remote intervention procedures. Previous studies utilizing remote 
interventions with participants in various medical and non-medical settings have reported excellent 
feasibility and acceptability rates. For example, Wakefield et al. (2016), in a sample of parents of 
children who survived cancer, reported a 96% completion rate after a 6-month, online, group-based, 
cognitive behavioral therapy intervention (CBT). In another study, Beatty et al. (2016) evaluated 
the efficacy of a 6-week self-guided Web-based CBT to reduce distress among cancer patients and 
reported a study acceptance rate of 63.2% of eligible patients. Moreover, the research interest and 
the need for new and remote modes of delivery for psychological interventions has become even 
more salient in the past year in response to the Covid-19 outbreak. In an ongoing study during the 
pandemic, this author has been adapting a well-being intervention similar to the present study for 
complete remote delivery through teleconferencing software and preliminary anecdotal findings 
suggest that retention rates are very high. This suggests that transition to more remote strategies that 
make psychological interventions more accessible to participants could improve intervention 
acceptability and retention rates even further. 
No specific effect of the well-being intervention was found with respect to weight change. In 
fact, there were no significant differences in weight loss between the group receiving the combined 
well-being and lifestyle intervention and the group receiving the lifestyle intervention alone. These 
findings are in line with those from another study (Phillips et al., 2017), in which the combination 
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of a positive affect (i.e., participants were asked to identify and think about small things that made 
them feel good on waking up and during the day) and self-affirmation (i.e., participants were asked 
to think about a proud moment in their life when facing barriers to their behavioral goals) 
component with a lifestyle intervention was not associated with significantly greater weight loss at 
12 months compared with the lifestyle intervention alone. In both this latter study and our study, the 
lifestyle intervention was based on a small change approach that relies on small sustained lifestyle 
changes to reduce energy intake and increase energy expenditure in order to promote gradual 
weight loss (Hill, 2009; Hills et al., 2013). Previous studies using this approach have shown a 
statistically significant and sustained weight loss across different populations of adult participants 
who were overweight or obese (Crane et al., 2020; Damschroder et al., 2010, 2014; Lutes et al., 
2008, 2012, 2017; Paxman et al., 2011; Vimalananda et al., 2016; Zinn et al., 2012). Similarly, in 
our study, participants in both the combined WBT-lifestyle and lifestyle alone groups received a 
small change intervention and experienced a statistically significant weight loss from baseline to 
post-intervention that was sustained at 6-month follow-up. A total weight loss of at least 5% is 
considered to be clinically significant, since it has been associated with improvements in 
cardiovascular risk factors such as HbA1c, systolic and diastolic blood pressure, triglycerides, and 
total, HDL, and LDL cholesterol (Brown et al., 2016; Wing et al., 2011). Among completers in our 
study, a clinically significant weight loss of 5% was observed in 25.6% of the total sample at post-
intervention and 31% at 6-month follow-up, without significant differences between the combined 
WBT-lifestyle and lifestyle alone groups. Similarly, in the studies by Zinn et al. (Zinn et al., 2012) 
and Damschroder et al. (Damschroder et al., 2014), about 30% of participants lost at least 5% of 
their initial body weight during a small change intervention. Also, one study showed a clinically 
significant weight loss greater than 5% during a small change treatment program delivered in group 
for 3 months and over the phone for an additional 6 months (Lutes et al., 2012). On the other hand, 
in the study by Phillips et al. (2017), only 9% of all participants lost at least 7% of their initial body 
weight at post-intervention (12 months). To the best of our knowledge, our study is the first to have 
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tested a small change intervention by focusing exclusively on a population of patients with type 2 
diabetes. An exploratory post hoc analysis by Lutes et al. (2017) revealed that participants with a 
diagnosis of diabetes experienced worse weight loss outcomes during a small change intervention 
when compared with those without diabetes, which they conjecture may be related to the higher 
level of emotional distress present in diabetic populations, and therefore the more negative effect on 
these participants of losing social support as the group sessions in the study became less frequent 
over the course of the long-term follow-up. Considering this, our findings are particularly promising 
since, although we did not find a significant effect from the well-being intervention on weight loss, 
they show the efficacy of the small change approach in a population of patients with type 2 
diabetes. Exploratory subgroup analyses were conducted to determine for which participants the 
combined WBT-lifestyle intervention had the most advantages in terms of weight loss. Student’s t-
test with Bonferroni correction was used to compare the group of WBT-lifestyle participants who 
reached a clinically significant weight loss at either immediate post-intervention or 6-month follow-
up with those who did not in terms of baseline demographics, medical, psychological, and lifestyle 
variables. No significant difference was found. However, these results are to be considered with 
caution due to the small sample size and large number of candidate predictors at baseline. 
Significantly greater improvements in measures of depression and hostility, as assessed by 
the SQ (Benasi et al., 2020; Kellner, 1987), and personal growth, as assessed by the PWBs (Ryff, 
1989), were observed at post-intervention in the group receiving the combined well-being and 
lifestyle intervention. This is particularly important when considering the high prevalence of 
various forms of psychological distress among patients with type 2 diabetes. The prevalence of 
depression has been found to be nearly twice as high among people with type 2 diabetes compared 
to the general population (Roy & Lloyd, 2012), and according to a recent systematic review and 
meta-analysis of observational studies, almost one in four adults with type 2 diabetes had a 
comorbid depressive disorder (Khaledi et al., 2019). Other forms of psychological distress that are 
prevalent among patients with type 2 diabetes include anxiety disorders (Chaturvedi et al., 2019), 
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subthreshold depression (Schmitz et al., 2014), and diabetes-related distress (Dennick et al., 2017; 
Polonsky et al., 1995). In a case control study (Dogan et al., 2019), higher levels of anger-hostility 
were observed among patients with type 2 diabetes compared to non-diabetic patients. Even if in 
our study we specifically excluded patients with an untreated, severe, and/or recently diagnosed 
psychiatric disorder, 9% of the sample met the diagnostic criteria for minor depression, and self-
reported levels of psychological distress were generally higher than those observed in populations 
of healthy individuals (Kellner, 1987; Kellner et al., 1989; Mangelli et al., 2006; Sonino et al., 
2011). Whether it meets full diagnostic criteria for a psychiatric disorder or not, the presence of 
psychological distress has been linked to poor health behaviors and clinical outcomes, including 
poorer treatment adherence, glycemic control, diet and quality of life, lower physical activity, and 
higher rates of diabetes-related complications, disability, and mortality (Dirmaier et al., 2010; Dong 
et al., 2020; Guerrero Fernández de Alba et al., 2020). Hostility, in particular, has been associated 
with worse metabolic outcomes, systemic inflammation, and higher rates of cardiovascular 
morbidity and mortality in patients with diabetes (Elovainio et al., 2011; Hackett et al., 2015; 
Jonasson et al., 2019; Todaro et al., 2005). According to a recent study, depressive symptoms may 
have a role in mediating the association between hostility and cardiovascular risk (Hamieh et al., 
2020). On the other hand, different indicators of psychological well-being have been associated 
with better health outcomes across numerous medical conditions (Chida & Steptoe, 2008; Ryff, 
2014). Among patients with type 2 diabetes, positive psychological characteristics, such as positive 
affect, self-efficacy, resilience, and optimism have been associated with better glycemic control, 
fewer diabetes-related complications, and lower mortality rates (Celano et al., 2013). In a 
longitudinal study, the association between distress and worsening of glycemic control and self-care 
behaviors was significantly stronger among diabetic patients with low to moderate levels of 
resilience than among those with high levels of resilience, showing the protective role of resilience 
in response to distress (Yi et al., 2008). These data suggest the importance of addressing factors 
related to psychological distress and well-being when developing effective interventions for 
 113  
diabetes. In our study, we implemented an intervention to promote psychological well-being and 
reduce psychological distress in line with the WBT protocol (Fava, 2016a). While this innovative 
short-term psychotherapeutic strategy yielded enduring clinical benefits in the psychiatric setting, 
particularly with regard to recurrent depression (Fava et al., 1998), its application in the medical 
setting is still new. In a recently published study by Rafanelli et al. (2020), among depressed and/or 
demoralized patients with acute coronary syndrome, the sequential combination of cognitive 
behavioral therapy (CBT) and WBT was associated with significantly greater improvements in 
depressive symptoms compared to an active control group receiving clinical management alone at 
immediate post-intervention. Improvements were maintained in both the combined WBT-lifestyle 
and lifestyle alone groups, but differences between groups were no longer significant starting from 
a 3-month follow-up after the end of the intervention. Similarly, in our study, lack of significant 
differences between groups in measures of psychological distress at 6-month follow-up was not 
associated with a loss of improvement in the well-being and lifestyle intervention group, but to a 
reduction in distress in the lifestyle alone intervention group. A previous study has shown that 
behavioral lifestyle interventions for weight loss can improve psychological health in patients with 
type 2 diabetes and obesity even without a psychological component (Brinkworth et al., 2016). 
Considering this, it is possible that in our study adding a well-being component to the lifestyle 
intervention resulted in a faster improvement in psychological outcomes.  
For the assessment of psychological states in this study, we relied on self-reported measures 
with good clinimetric properties such as the SQ (Benasi et al., 2020; Kellner, 1987). A clinimetric 
approach for the evaluation of clinical issues has been introduced by Feinstein in 1982 (Feinstein, 
1982) as an alternative to the traditional psychometric model. According to the clinimetric 
approach, the psychometric model, with its focus on the homogeneity of items (e.g., Cronbach’s 
alpha tests) as the main criterion of validity and reliability of a rating scale, appears to be 
inadequate for the understanding of clinical challenges (Bech, 2004; Fava et al., 2004). In fact, a 
scale with a high internal consistency or homogeneity may be redundant and have a decreased 
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ability to identify differences and change (Fava et al., 2004). In clinimetrics, homogeneity is not 
necessary, and the quality of an instrument is judged based on its sensitivity, which can be 
described as its ability to discriminate between different patient populations, and detect clinically 
significant changes in health status over time and with treatment (Kellner, 1972). The use of 
sensitive scales can therefore allow the identification of psychological states, including both 
symptoms of distress and well-being, and their changes with treatment, even when these changes 
are present with a small effect size and limited sample size (Benasi et al., 2020). 
 The combined WBT-lifestyle intervention showed a sustained and moderate to large effect 
in promoting physical activity compared to lifestyle alone. Specifically, at 6-month follow-up, 
levels of physical activity were significantly higher among participants in the combined WBT-
lifestyle intervention but started to decrease among those who received the lifestyle intervention 
alone. These positive findings are in line with a newly proposed approach to physical activity that 
challenges the current focus on the risks associated with physical inactivity and the promotion of 
generic threshold-based recommendations, and advocates for a more person-centered approach that 
relies on self-empowerment and self-determination (Warburton & Bredin, 2019). Similarly, WBT 
recognizes individual variations and endorses a personalized approach in promoting lifestyle 
changes (Benasi et al., 2019; Fava, 2016b). Moreover, studies have suggested that more attention 
should be paid to physical activity in patients with type 2 diabetes (Zhang et al., 2020). In fact, even 
when not associated with clinically significant weight loss, an increase in physical activity can have 
several health benefits in diabetic patients, such as improvement of glucose and lipid profiles, 
increases in health-related quality of life, prevention of diabetes-related complications, and 
lowering of mortality rates (Karstoft & Pedersen, 2016; Munan et al., 2020; Tapehsari et al., 2020; 
Wake, 2020). The benefits of adding a psychological component to a standard lifestyle intervention 
for behavioral change have been previously reported in the literature. For example, in Martinus et 
al. (2006), the combination of psychological counseling and exercise training resulted in a 
significantly higher adherence to exercise compared to exercise training alone in patients with type 
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2 diabetes. Furthermore, Aikens et al. (2012) found a prospective association between depressive 
symptoms and future health behaviors, including physical activity. It is therefore possible that, in 
our study, short-term improvements in psychological distress may have had a positive impact on 
physical activity at follow-up. This is in line with the hypothesis that a state of euthymia may 
promote healthy lifestyle changes by modifying psychosocial factors that negatively impact the 
individual vulnerability, course, and outcome of medical disease. 
Finally, improvements in psychological distress at post-intervention and physical activity at 
follow-up do not appear to be associated with better physiological outcomes (i.e., HbA1c, HDL, 
LDL, triglycerides, and blood pressure), in the group receiving the combined well-being and 
lifestyle intervention. In fact, even if changes in blood pressure favored the combined intervention 
at 6-month follow-up with a medium to large effect size, differences between the combined WBT-
lifestyle and lifestyle alone groups were not statistically significant. In line with our results, several 
meta-analyses found a small or no effect on glycemic control from both psychosocial interventions 
to reduce distress and well-being interventions in patients with diabetes (Baumeister et al., 2014; 
Chew et al., 2017; Massey et al., 2019; Mathiesen et al., 2019). On the other hand, these findings 
are contrary to those of other studies in which better psychological outcomes and increased physical 
activity were associated with improved glycemic control (Fisher et al., 2010; Munan et al., 2020). 
Considering the delayed effect of the intervention on physical activity, it is possible that better 
physiological outcomes may have been detected at a longer-term follow-up in the group of 
participants receiving the combined WBT-lifestyle intervention. 
 
3.6.1 Study limitations 
Our findings need to be considered within the context of study limitations. First, the use of a 
treatment as usual waitlist control may have inflated the effect of the combined WBT-lifestyle 
intervention by artificially worsening outcomes in the lifestyle alone group. Wait-list controls have 
been controversial. For example, a meta-analysis comparing various strategies for control groups in 
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clinical trials found that a wait-list control may lead to deleterious effects, effectively a “nocebo”, 
compared to no treatment at all (Furukawa et al., 2014). As an alternative, an active intervention 
control group (e.g., receiving the same amount of study contact while receiving only treatment as 
usual and no specific intervention) has been recommended (Guidi et al., 2018). 
Another limitation pertains to the use of stringent inclusion criteria related to age. We chose to 
exclude patients older than 65 years of age. We did this due to possible risks associated with weight 
loss in older adults (Waters et al., 2013). Moreover, older adults with diabetes may have more 
medical complications, and we hoped that limiting our sample to younger patients would result in a 
more homogeneous sample. However, the prevalence of type 2 diabetes among those older than 65 
years of age is 26.8% compared to 17.5% in patients between 45 and 64 years old and 4.1% in 
patients between 18 and 44 years old (Centers for Disease Control and Prevention, 2020c). This 
limits the generalizability of our findings to a specific population of patients with type 2 diabetes. 
Furthermore, restricting recruitment to a working age population may have impacted the acceptance 
rate. In fact, lack of time due to work and family constraints was a common reason for refusing 
participation but also interrupting participation.  
The use of self-reported questionnaires for the assessment of physical activity could have led to 
bias, while an objective assessment (e.g., accelerometers, pedometers, actigraph, etc.) could have 
provided a more accurate estimate. 
Finally, physiological parameters were collected from medical charts and were not available for 
all participants, resulting in a great number of missing data leading to loss of statistical power and 
potential bias if data were not missing at random. Including a direct collection of blood samples as 
part of the study protocol would have assured accuracy and completeness of physiological data. 
 
3.7 General conclusions and implications  
The present study is the first to test the feasibility, acceptability, and superiority of an 
intervention modeled after WBT in combination with small change lifestyle elements to promote 
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weight loss and reduce distress in a population of adult patients with type 2 diabetes compared to 
lifestyle changes alone.  
Preliminary findings suggest that not only can a combined well-being and lifestyle 
intervention be feasible and acceptable in the setting of an outpatient diabetes clinic, but also that a 
well-being intervention can be a valuable addition to lifestyle interventions in improving short-term 
psychological outcomes and promoting healthy changes in physical activity at 6-month follow-up. 
Moreover, although no significant effect of the well-being intervention was found in terms of 
weight loss, promising results were found within each group, demonstrating for the first time the 
efficacy of a small change intervention to promote weight loss in patients with type 2 diabetes 
specifically. 
The feasibility data generated in this study may be valuable for informing the design of 
future studies. Considering the challenges and limitations which emerged in the present study, 
investigators should consider: replicating our findings in a population of adults ≥ 65 years of age, 
which is more representative of the overall population of patients with type 2 diabetes; utilizing 
objective measures of lifestyle change in order to ensure accurate assessment of physical activity; 
including a plan for standardized, direct collection of physiological parameters to ensure accuracy 
and completeness; replacing the treatment as usual wait-list control group with an active 
intervention control group; and assessing participants at longer follow-ups. Also, the effect size 
estimates of key efficacy outcomes may inform a sample size calculation for a larger superiority 
trial. 
Finally, it may be beneficial to design alternative ways to deliver the intervention, such as 
those implemented in telemedicine, to meet both participants’ personal needs related to work and 
family constrains and current safety challenges, and therefore potentially increase acceptance and 
retention rates. 
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